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ABSTRACT 
Mitochondria fulfill essential roles in a variety of cellular processes, including 
ATP generation, Fe-S cluster biogenesis, amino acid metabolism, lipid metabolism, and 
various signaling pathways.  Consistent with their contributions to various processes, 
mitochondrial dysfunction leads to a wide range of diseases and disorders, including 
diabetes, neurodegenerative disorders, heart failure, and cancer.  To protect cells from 
mitochondrial dysfunction and subsequent disease, cells have developed a network of 
pathways responsible for maintaining mitochondrial quality.  One of these pathways 
depends on the Vms1-Cdc48 protein complex.  This complex localizes diffusely 
throughout the cytosol under unstressed conditions, but translocates to mitochondria in 
response to stress and aids in the degradation of mitochondrial proteins. 
Using Saccharomyces cerevisiae, we have determined how this stress-responsive 
localization to mitochondria is regulated.  Mitochondrial targeting of Vms1 is mediated 
by a conserved Mitochondrial Targeting Domain (Vms1MTD), which is inhibited by 
intramolecular interactions with a N-terminal Leucine Rich Sequence (Vms1LRS) under 
unstressed conditions.  In response to oxidative stress, Vms1LRS inhibition of the Vms1MTD
is relieved and Vms1 localizes to damaged mitochondria.
Using a combination of genetics, biochemistry, and molecular biology, we 
determined that ergosterol peroxide (EP) is the receptor to which Vms1 localizes.  EP is 
formed from the nonenzymatic oxidation of ergosterol by reactive oxygen, specifically 
singlet oxygen.  The same stress conditions that promote Vms1 localization to 
mitochondria induce the accumulation of mitochondrial EP.  This leads us to hypothesize 
that EP levels manifest the degree of stress within a mitochondrion.  Furthermore, we 
suggest that accumulation of EP contributes to disrupting the inhibitory interaction 
between the Vms1MTD and Vms1LRS, enabling Vms1 to be preferentially recruited to 
damaged mitochondria 
 We have also demonstrated that sphingolipids are required for efficient Vms1 
translocation to mitochondria.  However, we were unable to identify a physiologically 
relevant sphingolipid species to which Vms1 binds directly.  Rather, we hypothesize that 
sphingolipids are necessary to create lipid microdomains, which help stabilize sterols, 
such as ergosterol peroxide, in the outer mitochondrial membrane.  Taken together, the 
studies described herein illustrate novel coordination between lipid signaling and 
mitochondrial quality control pathways. 
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 For many decades, lipids were not recognized as significant contributors to active 
cellular processes; rather, they were thought to primarily contribute to energy storage and 
establishing membrane structure.  This manner of thinking has evolved within the last 25 
years, as new studies have demonstrated active functions for lipids in a wide range of 
cellular processes.  Lipids fulfill these functions primarily through interactions with other 
lipids or proteins.  Lipid-lipid interactions often alter the structure or architecture of a 
membrane, and lipid-protein interactions often modulate the activity of the interacting 
protein.  Many cellular processes and pathways, including those regulating mitochondrial 
quality and function, are strongly influenced by signaling through phospholipids, 
sphingolipids, and sterols. 
 
Introduction 
Lipids are a class of macromolecules essential for life.  Lipids are hydrophobic or 
amphipathic small molecules, belonging to one of the following 8 subclasses: fatty acids, 
glycerolipids, glycerophospholipids, sphingolipids, saccharolipids, polyketides, prenol 
lipids, and sterol lipids (Fahy et al., 2009).  Historically, lipids were thought to contribute 
almost exclusively to energy storage and membrane structure.  However, studies 
conducted over the last quarter of a century have demonstrated that lipids play an active 
role in various cell signaling platforms, in addition to fulfilling structural and energy 
storage roles (Hannun and Obeid, 2008).  This is achieved through two general 
mechanisms: lipid-lipid interactions and lipid-protein interactions.  Through the 
mechanism of lipid-lipid interactions, increasing levels of a lipid species can alter the 
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biophysical properties of a membrane, thereby affecting membrane architecture and the 
ability of proteins and other molecules to interact with the membrane (Fahy et al., 2009).  
Lipid-protein interactions can regulate the function of target proteins by modulating their 
activity or by targeting proteins to specific regions in the cell, where they can be activated 
or enabled to act upon designated substrates (Hannun and Obeid, 2008). 
The abundance of individual bioactive lipids within the cell strongly influence the 
mechanism whereby each lipid contributes to cell signaling (Hannun and Obeid, 2008).  
Changes in the abundance of lipid species making up a very small percentage of the total 
lipid content, such as sphingosine-1-phosphate, are not likely to alter the biophysical 
properties of a membrane.  Rather, these lipids are more likely to interact with high-
affinity receptors that can detect these lipids, and changes in their abundance, even at 
very low concentrations.  Lipids of medium abundance, such as ceramide, might act on 
receptors of medium affinity and contribute to altering biophysical properties of 
membranes, especially when conditions lead to large changes in levels of these lipids.  
Lastly, abundant lipids are most likely to cause changes to the organization and 
biophysical properties of a membrane when their levels change.  In this dissertation, we 
will examine how lipids from multiple lipid families contribute to cell signaling, with a 
specific focus on signaling pathways that regulate mitochondrial function and quality. 
 
Signaling Through Phospholipids 
 Phospholipids make up the majority of lipid content in cellular membranes and 
can be very diverse in their abundance and structure (Fahy et al., 2009).  One example of 
a phospholipid found in low levels in the cell that contributes actively to cell signaling is 
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phosphatidylinositol 4,5-bisphosphate, known simply as PI(4,5)P2.  PI(4,5)P2 is converted 
into various signaling molecules during G-protein coupled receptor (GPCR) activation 
(Lappano and Maggiolini, 2011; Newton, 1995).  GPCR activation leads to the 
production of two enzymes, phospholipase C (PLC) and phosphoinositide 3-kinase 
(PI3K) (Czech, 2000).  PLC hydrolyzes PI(4,5)P2 to produce inositol trisphosphate (IP3) 
and diacylglycerol (Chu et al., 2013).  IP3 is soluble, freely moving through the cytoplasm 
where it binds to the inositol trisphosphate receptor (IP3R), a Ca2+ channel in the 
endoplasmic reticulum (ER) (Baile et al., 2013).  IP3 binding to IP3R induces the release 
of Ca2+ from the ER into the cytoplasm, which then triggers various downstream Ca2+-
dependent signaling events (Czech, 2000; van Rheenen et al., 2005).  Meanwhile, DAG 
remains bound to the membrane where it recruits and activates members of the protein 
kinase C (PKC) family, which then modulate numerous cellular processes (Lappano and 
Maggiolini, 2011).  Alternatively, PI3K phosphorylates PI(4,5)P2 to generate 
phosphatidylinositol 3,4,5-trisphosphate (PIP3).  PIP3 then activates downstream 
components, such as the protein kinase AKT, which activates pathways required for cell 
growth and survival (Czech, 2000). 
 Cardiolipin is a unique phospholipid, making up almost 20% of the lipid content 
in the inner mitochondrial membrane (IMM) of eukaryotes.  In healthy mitochondria, 
cardiolipin is found almost exclusively in the IMM, possibly with higher levels in the 
inner leaflet compared to the outer leaflet (Paradies et al., 2014).  However, recent studies 
demonstrate that mitochondrial injury and depolarization cause a significant portion of 
cardiolipin to become externalized to the cytosolic leaflet of the outer mitochondrial 
membrane (OMM) through mechanisms that have not been well-defined (Baile et al., 
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2013; Chu et al., 2013; Kagan et al., 2014).  Cardiolipin-interaction sites on LC3, a 
component of the autophagy machinery, recognize cytosolic-exposed cardiolipin, leading 
to autophagosome formation and elimination of the damaged mitochondria through the 
process of mitophagy (Chu et al., 2013; Kagan et al., 2014).  These data suggest that the 
redistribution of cardiolipin from the IMM to the OMM, in response to injury, acts as a 
signal to promote mitophagic elimination of damaged organelles (Chu et al., 2013).  
Additional studies demonstrate that membranes containing cardiolipin display enhanced 
affinity towards Beclin 1, another member of the autophagic machinery, (Huang et al., 
2012), further suggesting that cardiolipin contributes to regulating mitophagy. 
 
Signaling Through Sphingolipids 
One of the most studied bioactive sphingolipids, sphingosine-1-phosphate (S1P), 
is a critical regulator of various physiological and pathophysiological process, including 
cancer, diabetes, and atherosclerosis.  S1P is secreted from the cell to bind 1 of 5 GPCRs, 
in order to regulate cell proliferation, angiogenesis, migration, cytoskeleton organization, 
endothelial cell chemotaxis, immune cell trafficking, mitogenesis, and other processes 
(Maceyka et al., 2012).  Alternatively, S1P regulates processes intracellularly, through 
interaction with various proteins (Maceyka et al., 2012).  S1P binds and inhibits the 
histone deacetylases, HDAC1 and HDAC2, influencing histone acetylation and gene 
expression (Hait et al., 2009).  Other experiments identify additional proteins to which 
S1P binds and activates, including PKCδ (Puneet et al., 2010) and TRAF2 (Alvarez et al., 
2010), both of which contribute to activating NF-κB signaling.  One study (Strub et al., 
2011) shows that S1P binds PHB2, a highly conserved protein regulating mitochondrial 
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assembly and function.  Furthermore, they observed aberrant assembly and reduced 
activity of complex IV of the electron transport chain in mice lacking SPHK2, the 
enzyme responsible for phosphorylating sphingosine to generate S1P, suggesting that 
S1P is important for complex IV assembly and mitochondrial respiration (Strub et al., 
2011). 
Ceramide, another sphingolipid, has been implicated in various signaling 
pathways affecting mitochondrial function.  In C. elegans, mitochondrial defects are 
detected by a surveillance pathway, which induces the expression of mitochondrial 
chaperone genes, such as hsp-6 (Kimura et al., 2007).  One study (Liu et al., 2014) 
demonstrates that inhibition of sphingolipid and ceramide synthesis, either genetically or 
pharmacologically, prevents nematodes from activating hsp-6 in response to antimycin 
treatment.  Conversely, these treatments have no effect on the induction of ER stress 
reporters under ER-specific stress, suggesting a specific role for ceramides in the 
response to mitochondrial stress.  Furthermore, exogenous addition of C24-ceramide to 
these nematodes restores hsp-6 induction in the presence of antimycin, but does not 
induce hsp-6 in the absence of stress (Liu et al., 2014), suggesting that ceramide is 
necessary, but not sufficient, for the cellular response to this mitochondrial stress. 
Ceramide also plays a role in regulating mitophagy.  Expression of ceramide 
synthase 1 (CerS1) generates C18-ceramide, which localizes to the OMM.  C18-ceramide 
directly binds LC3II, which recruits autophagosomal machinery to mitochondria 
(Sentelle et al., 2012).  In this manner, C18-ceramide serves as a receptor or anchor for 
autophagosomes, selectively recruiting them to mitochondria and promoting mitophagy. 
Ceramide has also been implicated in promoting apoptotic signaling within 
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mammalian cells.  In response to environmental stress or inflammatory cytokine stimuli, 
Ser270 of neutral sphingomyelinase 1 (nSMase1) is phosphorylated by c-Jun N-terminal 
kinase.  Phosphorylation at Ser270 activates nSMase1, which hydrolyzes sphingomyelin 
to produce increasing levels of ceramide and promote apoptosis (Yabu et al., 2015).  
Additional studies have suggested a mechanism through which elevated ceramide levels 
promote apoptosis.  It is hypothesized that increased ceramide content in the OMM leads 
to the formation of ceramide channels, through which cytochrome c leaks and activates 
the apoptosis pathway (Siskind and Colombini, 2000).   
Additional studies provide compelling data that ceramide and the Bcl-2 family are 
intimately involved in regulating apoptosis.  Anti-apoptotic members of the Bcl-2 family 
of proteins inhibit ceramide-mediated apoptosis (Gottschalk et al., 1994; Zhang et al., 
1996).  Overexpression of the anti-apoptotic Bcl-2 interferes with ceramide accumulation 
and subsequent apoptosis, possibly by inhibiting nSMase1 activation (Sawada et al., 
2000).  Other experiments provide data, in vivo and in vitro, that suggest anti-apoptotic 
members of the Bcl-2 family prevent the assembly and/or promote the disassembly of 
ceramide channels (Siskind et al., 2008).  Other sphingolipids, such as sphingosine and 
dihydroceramide, also interfere with the formation of ceramide channels (Siskind and 
Colombini, 2000).   
There are also examples of positive cooperation between ceramide and members 
of the Bcl-2 family of proteins.  BAX translocates from the cytosol to mitochondria in 
response to exogenous ceramide addition (Kim et al., 2001; Kogot-Levin and Saada, 
2014).  Activated BAX at mitochondria and ceramide then work synergistically to form 
proteolipid pores through which cytochrome c can leak into the cystosol (Ganesan et al., 
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2010), further suggesting a relationship between sphingolipid metabolism and apoptotic 
signaling. 
 
Signaling Through Sterol Lipids 
 Sterol lipids are essential for signaling pathways regulating differentiation, steroid 
hormone synthesis, inflammation, mitochondrial quality control, and many others.  One 
of the pathways dependent on sterol lipids is the Hedgehog (Hh) signal transduction 
pathway.  Hh signaling controls multiple elements of development in metazoans, 
including cell migration, patterning, and regulating tissue homeostasis in various parts of 
the body (Eaton, 2008).  In a very simplistic view, the activity of Smoothened (SMO) 
enables nuclear translocation of a GLI transcription factor.  Patched (PTC) represses the 
activity of SMO (Murone et al., 1999).  Hh binding to PTC relieves PTC-mediated 
repression of SMO, enabling nuclear translocation of a GLI transcription factor.   
Sterol lipids influence the activity of Hh, PTC, and SMO (Eaton, 2008).  Hh is 
synthesized as a 45 kDa protein, which is cleaved to generate a 19 kDa fragment.  This 
19 kDa fragment is covalently linked to cholesterol at its C-terminus (Porter et al., 1996a; 
Porter et al., 1996b) and palmitoylated at its N-terminus (Pepinsky et al., 1998) in order 
to achieve full signaling activity (Chen et al., 2004; Gallet et al., 2003; Gallet et al., 
2006).  In the absence of this cholesterol modification, Hh trafficking is altered and 
signaling is reduced (Callejo et al., 2006; Gallet et al., 2006; Porter et al., 1996b).   
Hh signaling is also regulated through direct interactions between SMO and 
molecules that are structurally similar to sterols (Chen et al., 2002a; Chen et al., 2002b).  
It is hypothesized that PTC regulates the availability of these sterol-related SMO ligands, 
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possibly through a sterol sensing domain (Eaton, 2008).  Multiple oxidized sterols, 
referred to as oxysterols, positively regulate Hh signaling by binding to SMO (Nedelcu et 
al., 2013).  In one study (Corcoran and Scott, 2006), cholesterol biosynthesis was 
blocked, which stunted cell growth and inhibited the transcription of a Hh signaling 
reporter.  However, the addition of cholesterol restored transcription of the reporter and 
cell proliferation.  Morever, signal transduction was restored with ten-fold potency upon 
addition of various oxysterols (Corcoran and Scott, 2006). 
 In addition to influencing Hh signaling, oxysterols modulate several other 
pathways.  Sterol regulatory element binding proteins (SREBPs) regulate the cellular 
machinery for fatty acid and cholesterol biosynthesis upon becoming activated by 
SREBP cleavage activating protein (SCAP) (Goldstein et al., 2006).  Oxysterols regulate 
SREBP function by binding directly to Insulin-induced gene (Insig) proteins 
(Radhakrishnan et al., 2007).  This oxysterol-Insig complex binds to SCAP, preventing 
SCAP from processing and activating SREBPs (Sun et al., 2007).  Liver X receptors 
(LXR) are nuclear receptors that regulate cholesterol metabolism and homeostasis, which 
are activated upon binding to oxysterols (Peet et al., 1998).  Oxysterols also modulate the 
activity of estrogen receptors.  In a potentially deleterious manner, oxysterols antagonize 
the estrogen-dependent vasorelaxation of the aorta and repress re-endothelialization of 
the carotid artery (Umetani et al., 2007).  Lastly, several proteins conserved throughout 
eukarya, belonging to the oxysterol-binding protein-related family, bind to oxysterol 
ligands to regulate various processes, including cellular lipid metabolism, vesicle 
transport, cell adhesion, and JAK/STAT signaling (Ngo et al., 2010; Raychaudhuri and 
Prinz, 2010). 
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 Recently, we discovered a previously uncharacterized role for oxidized sterols in 
mediating mitochondrial quality control.  In S. cerevisiae, low levels of ergosterol are 
found in mitochondrial membranes.  These ergosterol molecules can be oxidized by 
reactive oxygen species (ROS), specifically singlet oxygen, to produce ergosterol 
peroxide (EP) (Bocking et al., 2000).  Under unstressed conditions, there are very low 
levels of EP in the OMM.  Under stress conditions, mitochondria produce increasing 
levels of damaging ROS, leading to increased amounts of mitochondrial damage 
(Kurihara et al., 2012) and elevated levels of EP.  EP is a mitochondrial receptor for 
Vms1, a protein adaptor for the AAA-ATPase, Cdc48.  This Vms1-Cdc48 complex is 
required for mitochondrial protein degradation and maintenance of mitochondrial 
function (Heo et al., 2010).  The Vms1-Cdc48 complex is preferentially recruited to 
damaged mitochondria (Heo et al., 2013), likely due to the elevated levels of EP in the 
OMM in response to stress.  In this manner, the levels of EP act as an indicator of stress 
within a single mitochondrion or as a call for help to maintain mitochondrial quality.  
 
Discussion 
 The roles of lipids in cell signaling make up a relatively new, but challenging, 
area of research.  Manipulating lipid levels in a specific and timely fashion to study lipid-
mediated signaling can be quite difficult.  Overexpression, knockdown, deletion, and 
inhibition of key lipid biosynthetic enzymes are blunt tools.  These manipulations take 
hours or days to take full effect, allowing cells the opportunity to compensate for these 
changes, possibly masking effects these lipid manipulations might have on signaling 
(Schultz, 2010).  New and creative approaches to acutely modulating lipid levels need to 
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be developed, possibly by targeting enzymes involved in lipid metabolism to specific 
membranes in the cell with chemical dimerizers (Feng et al., 2014).  In lipid research, we 
do not have the tools to genetically engineer affinity tags or other modifications to 
specific lipid species that would facilitate the study of how lipids contribute to specific 
signaling pathways.  Rather, tools must be chemically synthesized and introduced to 
living cells.  Synthetic lipid derivatives that can be introduced to and tracked within 
living systems have improved and will continue to enhance our ability to dissect 
signaling pathways, especially as the diversity of synthetic lipid derivatives increases. 
 Lipids actively contribute to both intracellular and extracellular signaling 
pathways regulating various cellular processes.  In many instances, lipids from various 
classes appear to cooperate to achieve a specific cellular outcome.  For example, 
cardiolipin, a phospholipid, and ceramide, a sphingolipid, both contribute to the induction 
of mitophagy.  Cardiolipin binds to LC3 (Chu et al., 2013) and ceramide binds to LC3II 
(Sentelle et al., 2012), leading to autophagosome recruitment and formation.  The 
diversity in the combinations of lipid species that might cooperate to achieve a specific 
outcome helps illustrate the tremendous number of lipid signaling possibilities that exist 
within the cell (Schultz, 2010). 
 Advances in the technology we use to understand lipid biology will undoubtedly 
increase our ability to determine how lipids contribute to various signaling pathways in 
the cell.  However, the greatest advancements in our understanding of how lipids mediate 
cell signaling will come as the manner in which we think about lipids continues to 
evolve.  As our view and understanding of lipids continues to evolve and expand, we will 
consider contributions from lipids in uncharacterized pathways and will undoubtedly 
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continue to discover novel roles for lipids in these pathways.  
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ABSTRACT Mitochondrial dysfunction is associated with the development of many age-relat-
ed human diseases. Therefore recognizing and correcting the early signs of malfunctioning 
mitochondria is of critical importance for cellular welfare and survival. We previously demon-
strated that VCP/Cdc48-associated mitochondrial stress responsive 1 (Vms1) is a component 
of a mitochondrial surveillance system that mediates the stress-responsive degradation of 
mitochondrial proteins by the proteasome. Here we propose novel mechanisms through 
which Vms1 monitors the status of mitochondria and is recruited to damaged or stressed mi-
tochondria. We find that Vms1 contains a highly conserved region that is necessary and suffi-
cient for mitochondrial targeting (the mitochondrial targeting domain [MTD]). Of interest, 
MTD-mediated mitochondrial targeting of Vms1 is negatively regulated by a direct interaction 
with the Vms1 N-terminus. Using laser-induced generation of mitochondrial reactive oxygen 
species, we also show that Vms1 is preferentially recruited to mitochondria subjected to oxi-
dative stress. These studies define cellular and biochemical mechanisms by which Vms1 locali-
zation to mitochondria is controlled to enable an efficient protein quality control system.
INTRODUCTION
Mitochondria are involved in many essential cellular processes, 
including ATP generation, heme biosynthesis, apoptosis, and amino 
acid/fatty acid metabolism (Calvo and Mootha, 2010). Mitochon-
drial impairment therefore is associated with the development of a 
broad spectrum of human diseases, from diabetes, heart failure, and 
cancer to neurodegenerative diseases (Lin and Beal, 2006). Accord-
ingly, maintenance of mitochondrial function is of critical importance 
to avoid a variety of human pathologies.
Previously we showed that VCP/Cdc48-associated mitochondrial 
stress responsive 1 (Vms1) promotes stress-responsive mitochon-
drial protein degradation by the ubiquitin/proteasome system 
(UPS) in yeast (Lin and Beal, 2006). Although it is cytoplasmic in 
normal conditions, Vms1 translocates to mitochondria in response 
to a variety of mitochondrial stressors (Heo et al., 2010; Tanaka et al., 
2010). Vms1 also promotes the recruitment of the UPS components 
Cdc48 and Npl4 to the mitochondria, where they facilitate protea-
somal protein degradation. The mammalian orthologue of Cdc48, 
known as VCP or p97, translocates to ubiquitinated mitochondria 
and mediates the degradation of ubiquitinated mitochondrial pro-
teins (e.g., Mfn1/2 and Mcl1) by the proteasome (Tanaka et al., 
2010; Chan et al., 2011; Xu et al., 2011). Moreover, increasing num-
bers of mitochondrial proteins located in each of the different mito-
chondrial compartments have been demonstrated to be targets of 
proteasomal degradation (Heo and Rutter, 2011; Livnat-Levanon 
and Glickman, 2011). Mitochondrial proteins are clearly targeted for 
UPS-mediated degradation, and the maintenance of mitochondrial 
function appears to rely on this protein degradation activity.
Identification of Vms1 and its function, in addition to providing 
insight into the mechanisms of mitochondrial protein degradation, 
has also raised a number of questions that remain to be addressed. 
Among them, we have focused on determining the underlying 
mechanism(s) by which the intracellular localization of Vms1 is regu-
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both the crude and highly purified mitochondrial fractions (Figure 
1C). The MTD-only Vms1 protein, however, was depleted from the 
PMS fraction and was found predominantly in the mitochondrial 
fractions (Figure 1C). The interaction between the MTD and mito-
chondria appears to be fairly stable due to its persistence through 
the multistep mitochondrial purification procedure.
Unlike the 182-417 mutant, the 1-417 mutant containing both 
the N-terminus and MTD exhibited a wild-type localization pattern. 
It was observed to have cytoplasmic localization until treatment with 
rapamycin (Figure 1B). This implies that the N-terminus negatively 
regulates the MTD-mediated mitochondrial targeting of Vms1 in 
normal conditions. On mitochondrial stress, however, this suppres-
sion is removed and Vms1 relocalized to the mitochondria.
We assayed each of these five deletion mutants for complemen-
tation of the vms1? rapamycin hypersensitivity phenotype and 
found that none of them can replace VMS1 function in vivo (Supple-
mental Figure S2A). We showed previously that mitochondrial re-
cruitment of Cdc48 and Npl4 is an essential Vms1 function, and this 
interaction is formed through the highly conserved VIM located 
near the extreme C-terminus of Vms1 (Heo et al., 2010). Mutants 
1-182, 1-417, and 182-417 lack this VIM sequence and therefore fail 
to recruit Cdc48 and Npl4 to mitochondria. As a result, these vari-
ants are incompetent to restore Vms1 function. Although the 417-
end mutant can form a stronger interaction with both Cdc48 and 
Npl4 than can the full-length Vms1 (Heo et al., 2010), loss of the 
MTD prevents its mitochondrial targeting even in the presence of 
stress stimuli, thus abolishing function. Finally, the 182-end mutant 
containing both the MTD and VIM could not rescue the vms1? mu-
tant phenotype either. For an unknown reason, this 182-end mutant 
does not form a stable interaction with Cdc48 and Npl4 (Supple-
mental Figure S2B). From our ongoing efforts to define the minimal 
length of functional Vms1, we found that Vms111-end is necessary and 
sufficient for full Vms1 function (Supplemental Figure S5A).
Direct, physical interaction between the Vms1 N-terminus 
and MTD
We hypothesized that the Vms1MTD targets Vms1 to mitochondria 
and that the N-terminal region (Vms11-182) acts to repress this target-
ing by direct interaction with the Vms1MTD. Therefore Vms11-182 and 
Vms1MTD were tested for interaction, using multiple complementary 
methodologies. First, we generated yeast two-hybrid constructs ex-
pressing either Vms11-182 or Vms1MTD as a fusion with either the Gal4 
DNA-binding domain (DBD) or activation domain (AD). In either ori-
entation, the Vms11-182 and Vms1MTD fusions together enabled robust 
growth, indicating that these domains interact, similar to the positive 
control Alix/Tsg101 interaction (von Schwedler et al., 2003), whereas 
none of the singly transformed fusions allowed growth (Figure 2A). To 
more rigorously test this interaction, we generated constructs ex-
pressing either Vms11-182 or Vms1MTD as a fusion with either the myc 
or hemagglutinin (HA) epitope tags. These constructs were expressed 
at physiological levels in a vms1 mutant strain from the native VMS1 
promoter. We performed immunoprecipitation experiments on 
strains expressing the appropriate combinations of these constructs, 
as well as negative controls. As expected, the Vms11-182 and Vms1MTD 
domains exhibited a robust interaction in either orientation (Figure 
2B). There was no evidence for either a Vms11-182–Vms11-182 or 
Vms1MTD–Vms1MTD interaction, consistent with Vms1 being mono-
meric as observed by gel filtration chromatography.
Vms11-182 suppresses mitochondrial localization of Vms1MTD
To further test the hypothesis that Vms11-182 prevents Vms1MTD-me-
diated mitochondrial targeting, we overexpressed the Vms11-182 
Vms1 is regulated. We find that an internal highly conserved region 
of Vms1, which we name the mitochondrial targeting domain (MTD), 
is necessary and sufficient for mitochondrial localization of the pro-
tein. Of interest, our data suggest that the Vms1 N-terminus nega-
tively regulates mitochondrial localization via a direct interaction. 
We propose that dissociation of this interaction upon mitochondrial 
stress promotes the mitochondrial translocation of Vms1. These ob-
servations made it imperative to understand the nature and location 
of the “mitochondrial stress” signal. Does the presence of mito-
chondrial stress in the cell promote a generalized response in which 
Vms1 translocates to all mitochondria nonspecifically? Alternatively, 
is the damaged subpopulation of mitochondria selectively marked, 
thereby enabling Vms1 to localize specifically to these mitochon-
dria? Our results demonstrate that focal oxidative damage induces 
specific mitochondrial localization, suggesting the marking of dam-
aged mitochondria. Combining these data, we propose a two-step 
model in which stressed mitochondria present or activate a “recep-
tor” specifically on the outer membrane of damaged mitochondria, 
which promotes the local dissociation of the Vms1 N-terminus/MTD 
interaction. The MTD is then free to mediate the stable localization 
of Vms1 and its associated proteins to mitochondria. Taken together, 
the results of this study provide insight into the mechanisms by 
which damaged mitochondria communicate with the rest of the cell 
to promote an effective stress response to maintain mitochondrial, 
cellular, and organismal viability.
RESULTS
Regulated mitochondrial localization of Vms1
Proteomics studies of yeast mitochondria suggested that Vms1 is 
found in purified mitochondria (Sickmann et al., 2003). As a result, 
we were surprised to observe almost exclusively cytoplasmic local-
ization of a fully functional Vms1–green fluorescent protein (GFP) 
fusion (Heo et al., 2010). However, in cells treated with mitochon-
drial stress inducers, Vms1-GFP localized to mitochondria in all cells 
(Heo et al., 2010).
The Vms1 protein contains three recognizable regions. The 
N-terminus contains a C2H2-type zinc finger domain (ZnF). The 
C-terminus contains an ankyrin repeat and predicted coiled-coil (CC), 
followed by the VCP interacting motif (VIM), which is responsible for 
VCP/Cdc48 interaction. Between these domains is a highly conserved 
region of unknown structure (residues 182–417), which we named the 
MTD (Figure 1A). To determine which of these regions is required for 
mitochondrial localization, we generated a series of N- and C-termi-
nal deletion mutants (Figure 1A). As shown in Figure 1B, the wild-
type protein was cytoplasmic in normal conditions but translocated 
to mitochondria upon treatment with rapamycin, which causes mito-
chondrial stress (Kissová et al. 2006; Heo et al., 2010; Pan, 2011). 
Deletion of the N-terminus (mutant 182-end), however, caused local-
ization to mitochondria both in the presence and absence of rapamy-
cin. Deletion of the C-terminal ankyrin repeat, coiled-coil, and VIM 
(mutant 1-417) had no effect on localization (Figure 1B). Deletion of 
the middle MTD region from either the N- or C-terminus resulted in 
a complete loss of mitochondrial localization even in the presence of 
rapamycin (mutants 417-end and 1-182). An N- and C-terminal trun-
cation containing only the MTD constitutively localized to mitochon-
dria (mutant 182-417). These data suggest that the MTD is necessary 
and sufficient for the mitochondrial localization of Vms1 (Supplemen-
tal Figure S1), which is repressed in-cis by the N-terminus.
The constitutive mitochondrial localization of the isolated MTD 
was verified by biochemical fractionation. In normal conditions, 
wild-type Vms1 was present in the whole-cell extract (WCE) and 
postmitochondrial supernatant (PMS) but was largely absent from 
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FIGURE 1: Mitochondrial localization of Vms1 requires the MTD and is inhibited by the N-terminus. (A) Schematic 
representation of the domain structure of full-length Vms1 and deletion mutants. Full-length Vms1 contains a ZnF, an MTD, 
an ankyrin repeat, a predicted coiled-coil region (CC), and a VIM. The percentage identity between S. cerevisiae and human 
Vms1 is indicated for each region. (B) The vms1? strain containing both a plasmid expressing mito-RFP and a plasmid 
expressing the indicated GFP-tagged Vms1 deletion mutant was grown in SD-Ura-Leu. On reaching mid–log phase, the 
culture was either treated with vehicle (left) or 200 ng/ml rapamycin (right) for 3 h. Note that the deletion mutants were 
expressed as C-terminal GFP fusions under control of the native VMS1 promoter. Representative images are shown for 
each. (C) The vms1? mutant containing a plasmid expressing a C-terminus HA-epitope tagged full-length wild-type (cen) or 
MTD-only mutant (Vms1MTD, 2µ) was grown in SGE-Ura medium. On reaching late log phase, cells were harvested and 
subjected to a mitochondrial isolation procedure as described. WCE, PMS, crude mitochondria (crude mito), and sucrose 
gradient–purified mitochondria (pure mito) were further analyzed for the presence of Vms1 by immunoblotting. Antibodies 
against actin (cytoplasm) or porin (mitochondria) were used to determine the purity of each fraction.
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half-life when expressed in isolation. Expres-
sion of the Vms11-182 fragment, however, 
significantly increased the levels of Vms1MTD, 
presumably by delaying protein degra-
dation. The increased steady-state accu-
mulation of Vms1MTD upon expression of 
Vms11-182 appears to be almost exclusively 
in the cytosol, consistent with the hypothe-
sis that the N-terminal fragment is impeding 
mitochondrial localization of the MTD.
When we performed the same experi-
ment using GFP-fused Vms1MTD expressed 
from a low-copy centromeric plasmid, over-
expression of Vms11-182 appeared to stabi-
lize Vms1MTD-GFP, as it was undetectable by 
immunoblotting without Vms11-182 expres-
sion (Figure 3B). Moreover, as in Figure 3A, 
most of the Vms1MTD was observed in the 
cytosolic fraction, not associated with mito-
chondria. Taken together, these data are 
consistent with the hypothesis that the MTD 
domain targets Vms1 to mitochondria and 
the N-terminal 182 residues represses this 
targeting through direct interaction with the 
MTD.
The role of the N-terminus/MTD 
interaction in regulating Vms1 
localization
To facilitate testing of the hypothesis that 
the N-terminus/MTD interaction regulates 
Vms1 translocation to mitochondria, we 
more precisely mapped the interacting re-
gions in the Vms11-182 and Vms1MTD frag-
ments. Using the yeast two-hybrid system, 
we generated a series of deletion mutants 
(Supplemental Figure S3) and found that 
Vms111-55 was necessary and sufficient for 
the interaction with the Vms1MTD (Figure 
4A, right). Mapping of the interaction to this 
small region raised the possibility of gener-
ating full-length Vms1 variants in which the 
N-terminus/MTD interaction was disrupted 
by point mutations. Such mutants would 
enable us to rigorously evaluate our hy-
pothesis that this interaction regulates 
Vms1 localization.
When we examined the sequence of 
Vms111-55 carefully, we found eight leucine 
residues located within this region that were 
disproportionately evolutionarily conserved 
(Figure 4B). When we aligned this Vms1 se-
quence with the consensus sequence for 
the leucine rich–repeat structural motif, Lxx-
LxLxxN/CxL (x is any amino acid, and L can be replaced by valine, 
isoleucine, or phenylalanine), we observed significant but not com-
plete homology. Leucine-rich repeats form an ?/? horseshoe fold 
that is typically involved in mediating protein–protein interactions 
(Kobe and Kajava, 2001). To test whether these conserved leucines 
in Vms1 are indeed involved in the Vms111-55/Vms1MTD interaction, 
we generated a mutant containing seven Leu-to-Ala mutations in 
Vms111-55 (MutA). This mutant did not interact with the Vms1MTD in 
fragment in-trans with Vms1MTD in yeast. This model would predict 
that overexpression of Vms11-182 might decrease the mitochondrial 
localization of Vms1MTD. As observed previously, Vms1MTD expressed 
on its own in a vms1? strain exhibited constitutive mitochondrial 
localization (Figures 1C and 3A). In contrast, upon overexpression of 
Vms11-182 under the galactose-inducible promoter, the majority of 
Vms1MTD remained in the PMS, unbound to mitochondria (Figure 
3A). As described previously, the Vms1MTD appears to have a short 
FIGURE 2: Vms11-182 and Vms1MTD physically interact in vivo. (A) The AH109 strain was 
transformed with plasmids expressing AD and DBD fusions with nothing (ev), the Vms11-182, or 
the Vms1MTD. AD-ALIX and DBD-TSG101 were used as a positive control. Each strain was 
streaked on an SD-Trp-Leu-His plate and grown at 30°C for 3 d. (B) For coimmunoprecipitation 
studies, the vms1? strain was transformed with plasmids encoding the Vms11-182 and Vms1MTD 
tagged with GFP, myc, or HA as indicated, all under control of the native VMS1 promoter. Each 
strain was grown to log phase in SD-Leu-Trp and harvested. The crude lysates from each strain 
were immunoprecipitated with anti-myc antibody, and Western blots were performed with 
anti-HA or anti-myc antibodies as indicated. Ten percent of crude lysate was loaded.
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MutD), however, no longer interacted with 
the MTD in the yeast two-hybrid assay 
(Figure 4A, right). We then introduced these 
mutations into HA-tagged Vms11-182 and 
performed coimmunoprecipitation experi-
ments with myc-tagged Vms1MTD. As shown 
in Figure 4C, the MutC mutant exhibited im-
paired MTD interaction, and the MTD inter-
action was completely lost in the MutD 
mutant.
To test the hypothesis that the N-termi-
nus/MTD interaction regulates Vms1 
localization, we generated a full-length 
version of Vms1 bearing the MutD muta-
tions (Leu23Leu28Leu31Leu33 to Ala23Ala28A-
la31Ala33), which completely disrupts this 
interaction. Before testing the effect of 
MutD on Vms1 localization, we first as-
sessed the functionality of this construct by 
ability to rescue a vms1? mutant. Unlike 
Vms1MutA mentioned before, full-length 
Vms1MutD was similarly functional to wild-
type Vms1 (Supplemental Figure S6). 
Although Vms1MutD steady-state accumula-
tion was not at the level of wild-type Vms1, 
it was significantly higher than Vms1MutA 
(Supplemental Figure S5B). We then exam-
ined the effect of these mutations on Vms1 
localization by expressing C-terminally 
GFP-tagged, full-length Vms1MutD in the 
vms1 mutant. As before, wild-type Vms1 
was cytoplasmic under normal conditions 
without any stressor (Figure 5A, top). Full-
length Vms1MutD, however, exhibited in-
creased mitochondrial localization com-
pared with the wild type (Figure 5A, 
bottom). To further test this enhanced mi-
tochondrial localization of Vms1, we per-
formed biochemical fractionation of cells 
expressing HA-tagged full-length wild-type 
Vms1 or Vms1MutD. In agreement with the 
fluorescence localization, we observed in-
creased Vms1MutD levels in purified mito-
chondria even after sucrose gradient purifi-
cation of crude mitochondria in normal 
conditions (Figure 5B).
Previously we showed that overexpression of Vms11-182 stabilizes 
and sequesters Vms1MTD in the cytoplasm (Figure 3, A and B). If 
these effects are dependent on the N-terminus/MTD interaction, 
overexpression of the Vms11-182, MutD variant should be ineffective. 
As expected, overexpression of the MutD variant had no effect on 
either MTD stability and expression level or on its mitochondrial lo-
calization (Figure 3, A and B). These data suggest that the N-termi-
nus/MTD interaction maintains Vms1 in the cytoplasm, whereas dis-
sociation leads to mitochondrial translocation of Vms1.
Vms1-centric regulatory signals controlling 
Vms1 localization
The foregoing observations encouraged us to attempt to identify 
the stimuli and mechanisms that regulate the N-terminus/MTD in-
teraction. One possible scenario is a change in posttranslational 
modification(s) of Vms1 upon stress stimuli. We performed 
the yeast two-hybrid assay, and introduction of these mutations in 
full-length Vms1 caused constitutive mitochondrial localization of 
Vms1 (Supplemental Figure S4). These data are consistent with our 
hypothesis that these leucine residues play a critical role in the for-
mation of the N-terminus/MTD interaction and this interaction re-
presses mitochondrial localization of Vms1. The MutA mutant of 
Vms1 failed to rescue the rapamycin hypersensitivity of the vms1? 
mutant (Supplemental Figure S5A). This is probably due to its insta-
bility and decreased steady-state levels, especially in cells treated 
with rapamycin (Supplemental Figure S5B).
We generated Vms1 variants in which a subset of the MutA resi-
dues were mutated to attempt to disrupt the N-terminus/MTD inter-
action while maintaining better protein stability (Figure 4B). We also 
included mutations targeting other highly conserved residues in this 
region. Among three new mutants generated, one of them (MutB) 
did not impair interaction with the MTD. The two others (MutC and 
FIGURE 3: Overexpression of Vms11-182 stabilizes Vms1MTD and sequesters it in the cytoplasm. 
(A) The JRY1734 strain (pep4::HIS3 prb2::LEU2 bar1::HISG lys2::GAL1/10-GAL4) was 
transformed with plasmids expressing C-terminally HA-tagged Vms1MTD (2µ) and empty vector 
(ev), N-terminally His12-tagged Vms11-182, or Vms11-182, MutD. Each strain was grown in SGE-Ura-
Trp media at 30°C. On reaching mid–log phase, galactose was added to a final concentration of 
0.4%. After additional growth for 4 h, cells were harvested and subjected to mitochondrial 
isolation as described. Representative images of three independent experiments are shown. 
(B) Same set of experiments as in A, performed using C-terminally GFP-fused Vms1MTD 
expressed under the VMS1 promoter rather than the HA-tagged Vms1MTD (2µ).
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FIGURE 4: Vms111-55 is necessary and sufficient for interaction with Vms1MTD. (A) The AH109 strain was 
transformed with plasmids expressing AD and DBD fusions with nothing (ev), Vms111-55, Vms1MutB, Vms1MutC, 
Vms1MutD, or Vms1MTD. AD-Vms11-182 and DBD-Vms1MTD were used as a positive control. Each strain was streaked 
on both SD-Trp-Leu (left, control) and SD-Trp-Leu-His (right) plates and grown at 30°C for 3 d. (B) Sequence 
alignment of Vms111-55 among VMS1 orthologues from other species. (C) For coimmunoprecipitation studies, the 
vms1? strain was transformed with plasmids encoding Vms11-182, Vms11-182, MutC, Vms11-182, MutD, and Vms1MTD 
tagged with myc or HA as indicated, all under control of the native VMS1 promoter. Each strain was grown to log 
phase in SD-Leu-Trp and harvested. The crude lysates from each strain were immunoprecipitated with anti-HA 
antibody, and Western blots were performed with anti-HA or anti-myc antibodies as indicated. Ten percent of 
crude lysate was loaded.
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Selective Vms1 recruitment 
to damaged mitochondria
The failure to find Vms1-focused regulatory 
events that were required for stress-respon-
sive translocation to mitochondria raised the 
possibility that Vms1 localization might be 
controlled by modification of mitochondria 
rather than modification of Vms1. To ap-
proach this issue, we sought to determine 
the location of the mitochondrial stress “sig-
nal.” Does the presence of mitochondrial 
stress cause a generalized recruitment of 
Vms1 to mitochondria across the entire cell? 
Alternatively, are damaged mitochondria se-
lectively marked such that they are specifi-
cally targeted for Vms1 localization? To en-
able localized oxidative damage of 
mitochondria, we utilized mitochondrially 
targeted KillerRed (mito-KillerRed; Bulina 
et al., 2006; Shibuya and Tsujimoto, 2012). 
KillerRed is a mutated form of red fluores-
cent protein (RFP; anm2CP) from the hydro-
zoan Anthomedusae that generates the re-
active oxygen species (ROS) singlet oxygen 
and superoxide upon irradiation with green 
light (Bulina et al., 2006). To first determine 
whether mitochondrial ROS induced by 
KillerRed irradiation was sufficient to induce 
Vms1 translocation to mitochondria, we irra-
diated entire fields of cells and monitored 
Vms1-GFP localization over time. By 30 min 
postirradiation, we observed colocalization 
of Vms1-GFP with mitochondria, which be-
came maximal at approximately 1 h (Figure 
6A). Conversely, Vms1-GFP showed no mito-
chondrial localization upon irradiation in cells 
expressing mitochondrial-targeted RFP that 
does not emit ROS (Supplemental Figure 
S8). It is important to note that the photo-
bleaching of the KillerRed fluorescence that 
we observed is an expected indication of its photoactivation (Bulina 
et al., 2006) and that KillerRed activation seems to modestly pro-
mote mitochondrial fragmentation but has little effect on mitochon-
drial position during the 60-min time course. We also verified that 
the observed GFP localization at mitochondria was specific for Vms1-
GFP, as cells expressing KillerRed alone did not show GFP localiza-
tion under identical exposure conditions (Supplemental Figure S9).
Having verified that KillerRed activation induced Vms1 localiza-
tion to mitochondria, we then focally irradiated only a subset of mi-
tochondria within cells and examined Vms1-GFP localization. As 
shown in Figure 6B and Supplemental Figure S10, localized irradia-
tion with green light caused cytosolic depletion of Vms1-GFP and 
preferential recruitment of Vms1 specifically to those mitochondria 
activated for superoxide generation. Quantification of many similar 
images (n ? 105) showed an increase in Vms1-GFP localization at the 
site of irradiated mitochondria (Figure 6C). This was accompanied 
by a depletion of cytosolic Vms1-GFP (Figure 6C), consistent with 
recruitment of cytosolic Vms1 to irradiated mitochondria. The levels 
of Vms1 at mitochondria distal to the site of irradiation were un-
changed by irradiation (Figure 6C). Taken together, these results 
suggest that damaged mitochondria display a signal(s) that facili-
tates specific Vms1 recruitment.
comprehensive proteomic profiling of Vms1 in the presence and 
absence of rapamycin, which robustly induces mitochondrial 
translocation. We mapped four serine and threonine residues lo-
cated within the Vms11-182 fragment exhibiting approximately a 
twofold reduction in phosphorylation levels upon rapamycin treat-
ment, raising the possibility that dephosphorylation might facili-
tate dissociation from the MTD and mitochondrial localization of 
Vms1 (Supplemental Figure S7A). Therefore we mutated all of 
these residues to alanine to mimic the fully dephosphorylated 
state and performed coimmunoprecipitation assays, as well as 
fluorescence imaging. These alanine mutations had no effect on 
the interaction with the Vms1MTD compared with the wild-type 
Vms11-182. Neither did this mutant exhibit any change in subcel-
lular localization relative to the wild-type control (Supplemental 
Figure S7, B and C). Mutation of these sites to glutamate also 
had no effect on Vms1MTD interaction or localization. Therefore, 
although phosphorylation of these residues within the Vms1 
N-terminus might play a role in regulating Vms1 function, it 
appears to be neither necessary nor sufficient to control Vms1 
localization. Zinc binding to the N-terminal zinc finger domain 
also is not required, as mutation of the two obligate cysteine resi-
dues had no effect on Vms1 localization.
FIGURE 5: Disruption of the Vms1 intramolecular interaction facilitates mitochondrial 
translocation of Vms1. (A) The vms1? strain containing a plasmid expressing GFP-tagged 
wild-type Vms1 or Vms1MutD was grown in SD-Ura medium. On reaching log phase, cells were 
subjected to fluorescence microscopy to detect Vms1 localization. Representative images are 
shown. (B) The vms1? strain containing a plasmid expressing HA-tagged wild-type Vms1 or 
Vms1MutD was grown in SD-Ura and harvested at log phase. Cells were then subjected to 
mitochondrial isolation and subsequent sucrose gradient purification. The same fraction of each 
sample was subjected to SDS–PAGE and subsequent Western blot. Antibodies against actin 
(cytoplasm) or porin (mitochondria) were used to determine the purity of each fraction. 
Representative images of three independent experiments are shown.
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DISCUSSION
Here we described a regulatory mechanism 
for Vms1 localization. In wild-type cells 
maintained in normal laboratory conditions, 
Vms1 was cytosolic, but in response to a va-
riety of stress stimuli, Vms1 translocated to 
mitochondria (Heo et al., 2010). We found 
that the MTD region of Vms1 is necessary 
and sufficient for mitochondrial localization. 
This is the most highly conserved region 
among Vms1 orthologues but has no signifi-
cant similarity to any protein outside of the 
Vms1 family (Supplemental Figure S1). In 
particular, the N-terminal 70 amino acids of 
this region are ?50% identical among the 
major eukaryotic VMS1 orthologues. It is 
tempting to speculate that this level of con-
servation implies a mechanism for Vms1 mi-
tochondrial targeting that is distinct from a 
simple protein–protein interaction. Resolv-
ing this question will most likely require the 
structure of the Vms1 protein and/or identi-
fication of a specific mitochondrial receptor 
of Vms1.
Our biochemical fractionation and in vivo 
imaging studies demonstrate that the mito-
chondrial targeting activity of the MTD is 
repressed by the Vms1 N-terminus, proba-
bly through direct physical association. On 
discovering this interaction, we hypothe-
sized that the interaction between Vms11-182 
and Vms1MTD might be disrupted in re-
sponse to mitochondrial stress stimuli, such 
as rapamycin, allowing the MTD to target 
Vms1 to mitochondria. In turn, Vms1 would 
recruit Cdc48 and Npl4 to mitochondria to 
carry out proteasomal degradation. At-
tempts to directly test whether the Vms11-182 
and Vms1MTD interaction is disrupted by mi-
tochondrial stress failed, in both coimmuno-
precipitation and two-hybrid experiments, 
due to technical problems with these sys-
tems. We were able to test the importance 
of this interaction in Vms1 localization, how-
ever, using a mutant incapable of forming 
the Vms11-182/Vms1MTD interaction. If the 
model is correct, disruption of this interac-
tion should increase the levels of mitochon-
drially localized Vms1. Indeed, when we in-
troduced mutations that impair the 
interaction in full-length Vms1, we observed 
elevated levels of mitochondrial Vms1 in 
both imaging and biochemical fractionation 
studies. Although we were unable to dem-
onstrate regulated dissociation of this inter-
action in vivo under physiological condi-
tions, we demonstrated that dissociation of 
this interaction by mutations liberates the 
MTD, which is sufficient to target Vms1 to 
mitochondria. We believe it is likely that 
the N-terminus/MTD interaction is intra-
molecular, as we saw no evidence of Vms1 
FIGURE 6: Vms1 exhibits preferential localization to ROS-exposed mitochondria. (A) Yeast cells 
expressing Vms1-GFP were transformed with a mitochondrially targeted KillerRed, which 
generates superoxide and singlet oxygen upon irradiation with green light. Cells were irradiated 
for 15 min with 572-nm light. After irradiation, Vms1-GFP localization was monitored by 
wide-field fluorescence microscopy every 10 min for 60 min. (B) The cells described were 
irradiated with a 543-nm HeNe laser at 100% intensity for 1 min and only in a small region of the 
cell (indicated by the yellow dot), which contained mitochondria. Vms1-GFP localization was 
monitored by confocal fluorescence microscopy for 60 min after irradiation. (C) Quantification of 
Vms1-GFP localization to irradiated mitochondria, nonirradiated mitochondria, and the cytosol is 
shown as described in Materials and Methods.
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interaction was not affecting Vms1 directly 
but was instead localized to the Vms1MTD 
target site, specifically mitochondria. We 
therefore reasoned that damaged mito-
chondria might harbor a recruitment signal 
for Vms1. This hypothesis was tested using 
mitochondrial KillerRed, which generates 
light-induced reactive oxygen species 
within the mitochondrial matrix. On a 
whole-cell level, irradiation caused mito-
chondrial localization of Vms1. More impor-
tantly, activation of mitochondrial KillerRed 
within a subset of mitochondria caused 
preferential localization of cytosolic Vms1 
specifically to that subpopulation without 
affecting Vms1 localization to nonirradiated 
mitochondria. Although this effect is highly 
statistically significant when quantified over 
a large number of replicates, the magnitude 
of the effect is rather modest. We suggest 
that the scale of the observed effect is likely 
to be an underrepresentation of the selec-
tivity of mitochondrial recruitment in more 
physiological situations. This is due to the 
experimental complexities inherent in this 
paradigm, including the spatially imprecise 
irradiation on our microscope system and 
the movement within cells of reactive oxygen species and their 
products. Both of these limitations tend to decrease the apparent 
spatial specificity of Vms1 recruitment. In spite of these challenges, 
this observation has important implications for the nature of the 
signal promoting Vms1 translocation. Although its identity remains 
unclear, that signal appears to specifically mark damaged 
mitochondria and promote the recruitment of cytosolic Vms1. This 
could have important implications for pathological situations 
that are characterized by the presence of mitochondrial damage or 
stress.
These data suggest that both the N-terminus/MTD interaction 
and a signal localized to damaged mitochondria play important 
roles in regulating Vms1 localization within the cell. We hypothe-
size that their functions are interrelated. One possible explanation 
is that a stress-responsive accumulation of one or more specific 
mitochondrial modifications (one possibility being ubiquitin conju-
gates) competes with the Vms11-182/Vms1MTD interaction. In this 
model (Figure 7), the Vms11-182/Vms1MTD interaction is stable in 
normal conditions, and this represses mitochondrial translocation. 
Under stress conditions, specifically those conditions that necessi-
tate the recruitment of the ubiquitin/proteasome system to mito-
chondria, the mitochondrial damage signal is accumulated. Cyto-
solic Vms1 binds to mitochondria possessing this signal, which 
then further promotes the open conformation, enabling a stable 
MTD/mitochondrial interaction.
The mitochondrial localization of the damage signal has interest-
ing implications. Under stress conditions, those mitochondria that 
are spared from damage are also spared from Vms1 recruitment. 
This marking system enables the specific recruitment of the machin-
ery to the sites where it is most needed. An analogous marking 
system appears to be operative under the more extreme case in 
which mitochondria are targeted for total degradation by autophagy 
(Youle and Narendra, 2011). Perhaps these two degradative systems 
are part of a continuum in which attempts are first made to rescue 
mitochondrial function through targeted protein degradation. If that 
oligomerization, but we cannot rule out the possibility that the 
N-terminus of one molecule of Vms1 can bind to and repress the 
mitochondrial localization of another molecule.
We observed that interaction with the N-terminus not only pre-
vents mitochondrial localization of the MTD, but also stabilizes it. As 
shown in our biochemical fractionation experiments, overexpres-
sion of Vms11-182 increased the Vms1MTD protein level, whereas 
Vms11-182,MutD did not. Consistent with these data, Vms11-417, MutD 
lacking this intramolecular interaction was unstable when expressed 
either in Escherichia coli or in yeast (J.M.H. and J.R., unpublished 
data). We therefore predict that the formation of this Vms1 intramo-
lecular interaction protects Vms1MTD from the exposure of hydro-
phobic and/or disordered regions to maintain a state that is latent 
but competent. On mitochondrial stress, however, this interaction is 
disrupted, which, in turn, facilitates mitochondrial targeting of the 
exposed Vms1MTD. This is consistent with our observations that ra-
pamycin and other stress conditions lead to reduced levels of Vms1, 
presumably a result of this active and unstable conformation.
One major remaining question relates to the nature of the signal 
that regulates the stability of the N-terminus/MTD interaction and 
thereby regulates mitochondrial localization. One possibility is the 
presence of protein(s) that interact with either the N-terminus or 
the MTD to modulate their affinity for one another. However, we 
have not observed such protein(s) preferentially bound to Vms1 in 
either the presence or absence of rapamycin treatment in our 
biochemical purification experiments. The second possible scenario 
is a change in posttranslational modification(s) on Vms1 upon stress 
stimuli. Although we found four sites of phosphorylation located 
within the Vms11-182 fragment that exhibit roughly twofold reduced 
levels of phosphorylation upon rapamycin treatment, our mutagen-
esis studies showed that phosphorylation of these sites was neither 
necessary nor sufficient to promote Vms1 translocation.
This led us to consider alternative regulatory mechanisms 
by which extrinsic factor(s) might regulate Vms1 localization. 
Perhaps the signal leading to disruption of the Vms1 intramolecular 
FIGURE 7: Intramolecular interactions regulate Vms1 localization to mitochondria. In resting 
and unstressed conditions, Vms1 is maintained in the cytosol through a stable intramolecular 
interaction between residues 1–182 and the MTD. Under stress conditions, specifically those 
conditions that necessitate the recruitment of the ubiquitin/proteasome system to mitochondria, 
a mitochondrial damage signal accumulates. Vms1 binds to mitochondria possessing this signal, 
which further promotes the disruption of the intramolecular interaction between residues 1–182 
and the MTD, enabling a stable MTD/mitochondrial interaction.
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Mitochondrial isolation
Cells were harvested at the indicated time point and subjected to 
mitochondrial preparation as previously described (Hao et al., 2009). 
Isolated mitochondria were further purified by sucrose gradient 
purification as described (Heo et al., 2010).
Yeast two-hybrid system
The yeast two-hybrid assay was performed following the manufac-
turer’s guidelines (Matchmaker Two-Hybrid System 3; Clontech, 
Mountain View, CA). The AH109 strain (MATa, trp1-901, leu2-3, 112, 
ura3-52, his3-200, gal4?, gal80?, LYS2 : : GAL1UAS-GAL1TATA-HIS3, 
GAL2UAS-GAL2TATA-ADE2, URA3 : : MEL1UAS-MEL1 TATA-lacZ) was 
transformed with various combinations of pGBKT7- and pGADT7-
based constructs harboring no insert, Vms11-182, Vms11-55, Vms11-55, 
MutA, Vms111-55, MutB, Vms111-55, MutC, Vms1MTD, or positive controls. 
These strains were then streaked on SD-Leu-Trp-His plates to test 
for growth, which was indicative of an interaction. 
Immunoprecipitation
Vms11-182 and Vms1MTD coimmunoprecipitation was performed as 
described (Hayden and Ghosh, 2008). The vms1? strain transformed 
with the indicated combinations of constructs was grown to log 
phase, harvested, resuspended, and lysed in solution A (50 mM 
Tris-HCl, pH 7.4, 50 mM NaCl, 0.2% Triton X-100, and protease 
inhibitor cocktails [Sigma-Aldrich, St. Louis, MO]). Cleared lysates 
were incubated with anti-Myc (Sigma-Aldrich) or anti-HA antibody 
(Covance, Berkeley, CA) for 1 h at 4°C, followed by incubation with 
recombinant protein G beads for 1 h at 4°C. After washing, bound 
proteins were eluted in SDS, separated by SDS–PAGE, and applied 
to Western blotting using anti-HA or -myc antibodies as indicated. 
Ten percent of crude lysates was loaded.
Vms1 purification in yeast
Yeast strain JRY1734 (pep4::HIS3 prb2::LEU2 bar1::HISG 
lys2::GAL1/10-GAL4), designed for efficient overexpression, was 
transformed with a plasmid expressing N-terminus His12-fused 
Vms11-417 under the galactose-inducible promoter as described 
(von Schwedler et al., 2003). Transformed cells were grown to mid–
log phase in SGlycerol (3%) ethanol (2%)–Ura medium. To induce 
the expression of Vms1, galactose was added to the final concentra-
tion of 0.2%, and cells were grown for an additional 4 h and 
harvested. To purify Vms1, cells were lysed and subjected to con-
ventional nickel affinity purification using nickel-nitriloacetic acid 
beads and following the protocol suggested by the vendor (Fisher 
Scientific, Pittsburgh, PA).
Mito-Killer irradiation and Vms1 localization
A strain expressing Vms1-GFP from the VMS1 locus (VMS1::VMS1-
GFP-HIS3MX) yeast cells was transformed with a plasmid encoding 
a GPD promoter–driven construct expressing Killer Red (Evrogen, 
Moscow, Russia) fused with the mitochondrial targeting sequence of 
Su9 in a pRS415 backbone. These cells were grown to log phase in 
SD medium lacking leucine and imaged using a Zeiss Axioplan 2 
Imaging microscope after 15 min of irradiation with 572-nm green 
light from an X-Cite Series 120 fluorescence lamp. In experiments 
requiring irradiation of a portion of the mitochondria, these cells 
were irradiated with a 543-nm-wavelength HeNe laser (100% inten-
sity) for 1 min and imaged with a FV1000XY Confocal IX81 micro-
scope (Olympus, Tokyo, Japan; University of Utah Fluorescence 
Microscopy Facility, Salt Lake City, UT).
To quantify Vms1-GFP localization, the average fluorescence in-
tensity was measured (Image J; National Institutes of Health, 
fails to restore mitochondrial bioenergetics, the entire organelle is 
then destroyed through autophagy.
Many lines of evidence suggested the existence of communi-
cation between mitochondria and other organelles, including the 
nucleus and endoplasmic reticulum. In this study, we provide an 
additional line of evidence that mitochondria communicate a 
damage signal to the cytosol. Although further studies are neces-
sary to define this mitochondrial-derived signal, it is clear that the 
cellular stress-response machinery, including the Vms1 system, 
recognizes this signal and acts to protect and repair mitochondria. 
The result is the maintenance of mitochondrial function under 
challenging conditions, which is necessary for cell and organismal 
viability.
MATERIALS AND METHODS
Yeast strains, media, and growth conditions
A W303a Saccharomyces cerevisiae strain (W303a MATa his3 leu2 
met15 trp1 ura3) was used as the parental and wild-type strain. 
Deletion mutant strains were generated by standard PCR-based 
homologous recombination methods in diploids, followed by spo-
rulation and tetrad dissection. Yeast were transformed by the lithium 
acetate method and grown at 30°C in SD medium (0.67% yeast 
nitrogen base, 2% glucose) with amino acids unless otherwise indi-
cated (Sherman, 1991).
Plasmid construction
Plasmids expressing C-terminally HA- and GFP-tagged Vms1 were 
generated as described (Heo et al., 2010). The VMS1 coding region 
and promoter was PCR amplified from genomic DNA and ligated 
in-frame into a pRS416-based vector containing a C-terminal HA3 or 
GFP tag. VMS1 deletion mutant constructs were PCR amplified from 
the VMS1 coding region corresponding to 544nt-end, 1249nt-end, 
1-546nt, 1-1251nt, and 544nt-1251nt, respectively. These fragments 
were ligated in-frame into a pRS416-based vector flanked by the 
endogenous VMS1 promoter and C-terminal GFP.
For constructs used in Vms11-182 and Vms1MTD coimmunoprecipi-
tation, regions corresponding to mutant 1-182 (Vms11-182) and mu-
tant 182-417 (Vms1MTD) were PCR amplified and ligated in-frame 
into a pRS416-based vector containing the endogenous VMS1 pro-
moter and a C-terminal HA3 (or Myc13) tag.
For constructs with mutations, the sewing PCR strategy was 
used. PCR-amplified VMS1 with mutations was ligated into the iden-
tical vector systems used for wild-type Vms1.
Fluorescence microscopy
The vms1? strain was transformed with both pVMS1-GFP (or pVMS1 
deletion mutant-GFP) and pMito-RFP plasmids. To test the effect of 
rapamycin treatment on Vms1 localization, strains were grown to log 
phase at 30°C in SD medium lacking both uracil and leucine, treated 
with vehicle or rapamycin (200 ng/ml) for 3 h, and imaged using a 
Zeiss Axioplan 2 Imaging microscope (Carl Zeiss, Jena, Germany) as 
described (Kondo-Okamoto et al., 2003). To test the localization of 
Vms1 mutant in normal conditions without any stressor treatment, 
the vms1? strain transformed with indicated Vms1 mutant was 
grown to log phase at 30°C in SD-Ura medium, stained with Mi-
totracker Red dye (Invitrogen, Carlsbad, CA), and subjected to im-
aging as described.
For Mitotracker Red staining, 200 µl of individual cultures were 
stained with 10 µl of 10 µM MitoFluor Red 589 (Molecular Probes, 
Eugene, OR) for a couple of seconds and washed three times with 
the same volume of media. Cells were then subjected to fluores-
cence microscopy as described.
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MITOCHONDRIAL STEROL OXIDATION CONTROLS 
VMS1 TRANSLOCATION TO MITOCHONDRIA 
Summary 
Mitochondrial dysfunction contributes to a variety of human diseases.  Cells have 
developed multiple pathways responsible for maintaining mitochondrial quality.  A 
critical component of one of these pathways is the protein Vms1, which translocates and 
transports the AAA-ATPase Cdc48 to damaged mitochondria under stress, and aids in the 
proteasome-dependent degradation of mitochondrial proteins.  Mitochondrial targeting of 
Vms1 is mediated by a conserved Mitochondrial Targeting Domain (Vms1MTD), which is 
inhibited through intramolecular interactions with a N-terminal Leucine Rich Sequence 
(Vms1LRS) under unstressed conditions.  We have identified an oxidized sterol, ergosterol 
peroxide (EP), which is necessary for Vms1MTD localization to mitochondria.  
Furthermore, we demonstrate that stress induces the accumulation of EP and promotes 
Vms1 binding.  These data support a model in which stress produces elevated levels of 
mitochondrial EP, which recruit Vms1 specifically to damaged mitochondria. 
 
Introduction 
Reactive oxygen species and mitochondrial damage 
 Many cellular processes depend on functioning mitochondria, including ATP 
generation, heme biosynthesis, calcium signaling, and more (Calvo and Mootha, 2010).  
Similarly, dysfunctional mitochondria lead to a wide variety of diseases and disorders, 
including diabetes, neurodegeneration, and many more (Lin and Beal, 2006).  One of the 
major causes of mitochondrial dysfunction is reactive oxygen species (ROS).  
Mitochondria are the major site of ROS production within the cell (Circu and Aw, 2010).  
Due to this proximity, ROS can often damage mitochondria and when the quality of 
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mitochondria is not maintained, cellular catastrophe ensues (Murphy, 2009). 
ROS are highly reactive and tend to react with the nearest molecules, such as 
proteins, lipids, and nucleic acids.  Oxidative damage to nucleic acids causes alterations 
to the purine and pyrimidine bases.  If these alterations are not repaired, the genetic code 
of an organism can become modified, which can lead to genetic defects and subsequent 
cellular and/or physiological distress (Tsuboi et al., 1998).  Protein oxidation results in 
fragmentation, the formation of protein-protein cross-linkages, and general loss of 
function as the protein backbone becomes oxidized.  Proteins damaged by oxidation can 
aggregate and inhibit critical processes, thereby becoming toxic to the cell (Costa et al., 
2007).  Peroxidation of membrane lipids alters the biophysical properties of a membrane, 
impairs cellular function, and may even cause cells to rupture.  Lipid peroxidation 
products can be more stable than the parent ROS, yet still maintain a high level of 
reactivity.  Due to their high reactivity and increased stability, lipid peroxidation products 
can diffuse to locations distant from the source of ROS and inflict damage to additional 
macromolecules, causing alterations in cell signaling and cellular toxicity (Ayala et al., 
2014; Niki et al., 2005). 
 
Proteostasis and disease 
 Many human diseases arise when protein homeostasis, or proteostasis, is 
disrupted.  The proteostasis network is comprised of pathways and machinery that control 
protein synthesis, folding, trafficking, and degradation (Powers et al., 2009).  Cystic 
fibrosis and Gaucher disease are characterized by inherited mutations that cause 
inefficient folding of specific proteins.  Because these proteins are unable to properly 
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fold, they are universally degraded, leaving the cell without the necessary machinery to 
produce chloride channels or facilitate complex lipid metabolism (Powers et al., 2009).  
Several neurodegenerative diseases are linked to aging and are associated with disrupted 
proteostasis, including the aggregation of Aβ in Alzheimer’s disease, exon1 fragment of 
huntingtin in Huntington’s disease, and α-synuclein in Parkinson’s disease.  These 
protein aggregates overwhelm the chaperone and degradation machinery in these cells 
and become toxic, leading to cell death (Balch et al., 2008).  It has been suggested that 
the proteostasis network in aged cells becomes burdened by the accumulation of proteins 
damaged by ROS or other oxidative metabolites, especially in nondividing cells, like 
neurons (Powers et al., 2009).  These oxidized proteins tend to misfold and aggregate 
placing high levels of stress on the cell, leading to disruption of essential cellular 
processes and cell death. 
 
Mechanisms of mitochondrial quality control 
Because mitochondrial proteins are highly susceptible to ROS-induced damage 
and intact mitochondria are necessary for critical cellular functions, it is essential that 
mitochondrial protein quality be maintained.  To achieve this quality control, cells have 
developed pathways for eliminating damaged organelles and removing misfolded or 
damaged mitochondrial proteins (Ni et al., 2015).  One of these systems is selective 
autophagy of mitochondria, or mitophagy.  During the process of mitophagy, depolarized 
organelles are ubiquitinated in a PINK1 and Parkin-dependent fashion, targeting them for 
engulfment in double-membraned vesicles.  These vesicles are then transported to the 
lysosome, or vacuole in yeast, where the highly acidic environment of the lysosome 
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degrades the organelles (Youle and Narendra, 2011).  Another pathway dependent on 
PINK1 and Parkin has been discovered more recently, in which mitochondrial oxidative 
stress induces vesicles containing oxidized proteins to bud off of damaged organelles.  
These mitochondria-derived vesicles are than transported to and degraded by the 
lysosome, independent of canonical autophagy machinery.  This mechanism may regulate 
mitochondrial quality faster and more efficiently than mitophagy, as complete 
mitochondrial depolarization is prevented and only damaged portions of the organelle are 
degraded (Ni et al., 2015).  
Mitochondria have developed additional mechanisms of removing damaged 
proteins without eliminating entire organelles.  A subset of conserved eukaryotic 
proteases plays a role in mitochondrial proteostasis.  Inner mitochondrial membrane 
(IMM) proteases, m-AAA, i-AAA, and Oma1 metalloproteases mediate proteolysis and 
removal of misfolded or unassembled subunits of the electron transport chain, which can 
promote ROS production and disrupt the integrity of the IMM (Bohovych et al., 2016; 
Martinelli and Rugarli, 2010). 
Another system responsible for degradation of some mitochondrial proteins is the 
ubiquitin-proteasome system (UPS).  Damaged proteins in the outer mitochondrial 
membrane (OMM) are ubiquitinated with K48-linked ubiquitin, targeting them for 
degradation by the proteasome (Heo and Rutter, 2011).  These proteins are extracted 
from the OMM and sent for proteasomal degradation by the AAA-ATPase, Cdc48 
(Livnat-Levanon and Glickman, 2011).  Cdc48 is an abundant protein found throughout 
the cell, which is recruited specifically to mitochondria by adaptor proteins, such as the 
recently discovered protein, Vms1 (Heo et al., 2010). 
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Stress-responsive mitochondrial localization of Vms1 
Vms1 is a protein with several highly conserved domains from yeast to humans.  
Through a conserved C-terminal motif, Vms1 stably interacts with Cdc48.  This Vms1-
Cdc48 complex is necessary for the degradation of some mitochondrial proteins.  In the 
absence of this complex, cells accumulate ubiquitinated mitochondrial proteins, display 
progressive mitochondrial failure, and have elevated levels of mitophagy.  Under 
unstressed conditions, Vms1 is found throughout the cytosol.  In response to stress, Vms1 
localizes preferentially to damaged mitochondria (Heo et al., 2013).  Mitochondrial 
targeting of Vms1 is mediated by a conserved Mitochondrial Targeting Domain 
(Vms1MTD), which is inhibited by intramolecular interactions with a N-terminal Leucine 
Rich Sequence (Vms1LRS) under unstressed conditions.  When the Vms1MTD is expressed 
in the absence of the Vms1LRS, the Vms1MTD constitutively localizes to mitochondria, in 
the presence or absence of stress (Heo et al., 2013).  This suggests the presence of a 
constitutive mitochondrial receptor for the Vms1MTD, and that the Vms1LRS inhibits the 
Vms1MTD from binding to this receptor in the absence of stress.  These data also suggest 
that stress induces the production of one or more signals that mark damaged 
mitochondria and disrupt the interaction between the Vms1LRS and Vms1MTD, allowing the 
Vms1MTD to bind to its mitochondrial receptor.  In order to better understand the stress-
responsive localization of Vms1 to mitochondria, we sought to identify the constitutive 
mitochondrial receptor to which the Vms1MTD binds and the stress signal that promotes 





Mitochondrial surface proteins are dispensable  
for Vms1 binding to mitochondria  
 Our initial efforts at identifying the constitutive mitochondrial receptor of Vms1 
focused on identifying a protein ligand.  We used strains from the Saccharomyces 
Genome Deletion Project to screen for a reduction of Vms1MTD localization to 
mitochondria in over 500 mutants, each lacking a gene encoding for a nonessential, 
nuclear-encoded, mitochondrial protein (Giaever et al., 2002).  None of the mutant strains 
caused a reproducible reduction in Vms1MTD localization to mitochondria (data not 
shown).  We next hypothesized that Vms1 was binding an essential protein on the 
mitochondrial surface, such as ubiquitin.  Other Cdc48 adaptor proteins recognize and 
bind ubiquitin to recruit Cdc48 to ubiquitinated substrates (Schuberth et al., 2004; Ye et 
al., 2003).  We tested the ability of recombinant Vms1 to bind deubiquitinated 
mitochondria in vitro and observed no difference in Vms1-binding to untreated 
mitochondria compared with deubiquitinated mitochondria (data not shown). 
 At this point, we began to question if Vms1 was binding a protein or some other 
type of molecule at mitochondria.  To test this hypothesis, we treated purified 
mitochondria either with vehicle or proteinase K.  Proteinase K is a serine protease with 
broad cleavage specificity and is frequently used for general protein digestion.  We 
observed efficient cleavage of cytosolic-exposed mitochondrial proteins, such as Tom22 
and Fzo1, but very little cleavage of OMM-imbedded and intramitochondrial proteins, 
such as Por1, Sdh1, Sdh2, and Mia40, suggesting that proteins on the mitochondrial 
surface had been digested and that mitochondrial integrity remained uncompromised 
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(Figure 3.1A).  When we assayed the ability of Vms1 to bind mitochondria, we observed 
no difference between Vms1 affinity to untreated mitochondria compared with proteinase 
K-treated mitochondria (Figure 3.1B and 3.1C), suggesting that mitochondrial surface 
proteins are dispensable for Vms1 binding to mitochondria.  
 
Vms1 binds mitochondrial lipid species 
 Mitochondrial membranes are composed primarily of lipids and proteins.  Since 
we observed that protein was dispensable for mitochondrial binding, we tested if Vms1 
directly bound mitochondrial lipids.  We observed that Vms1 was capable of binding to 
liposomes containing mitochondrial lipids (Figure 3.2A).  Over 90% of the lipids in 
mitochondrial membranes are phospholipids, while sphingolipids, sterols, and 
isoprenoids make up the remaining lipids (van Meer et al., 2008; Zinser et al., 1991).  We 
wanted to determine which general class of lipid species was responsible for Vms1 
binding in vitro.  Due to their reactive phosphodiester linkage, phospholipids are 
susceptible to hydrolysis by mild base, whereas sphingolipids and sterols are not (Guan et 
al., 2010).  We took advantage of this property to create liposomes containing total 
mitochondrial lipids or liposomes containing a lipid extract enriched for sphingolipids 
and sterols.  Interestingly, Vms1 exhibited enhanced binding to liposomes containing the 
sphingolipid and sterol-enriched lipid extract (Figure 3.2A). 
To identify which of these lipid species was responsible for Vms1 recruitment to 
mitochondria, we employed an unbiased natural products chemistry approach.  Using two 
orthogonal chromatographic methods, we planned to separate this extract into many 
fractions, determine which fractions bind Vms1, and continue this process until we had 
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isolated a single lipid species responsible for binding.  We began with reverse-phase high 
performance liquid chromatography (HPLC), which fractionates species based on their 
hydrophobicity.  Due to the large number of fractions we collected, we first pooled lipids 
from multiple fractions and identified which pooled fractions contained species that bind 
Vms1 when introduced into liposomes (Figure 3.2B).  We then made liposomes from the 
individual fractions making up the pooled fraction with binding activity, and determined 
that Vms1 bound specifically to lipids in a single HPLC fraction (Figure 3.2C). 
 Concurrently, we used normal phase thin-layer chromatography (TLC) to separate 
lipid species from the sphingolipid and sterol-enriched extract based on their polarity and 
head groups.  After separating the lipids by TLC, extracting lipids from the various TLC 
fractions, and incorporating the lipids into liposomes, we determined that liposomes 
containing lipids from a single TLC fraction were responsible for the majority of Vms1 
binding (Figure 3.2D).  Upon comparing the lipids found in the HPLC and TLC fractions 
that exhibited the highest specific binding activity towards Vms1, we identified a single 
TLC band that was present in both fractions and absent from the surrounding fractions 
lacking affinity to Vms1 (Figure 3.2E).  Analysis of these binding fractions by LC/MS 
identified a single species common between the two binding fractions and distinct from 
surrounding fractions, with a mass corresponding to the molecular formula, C28H44O3. 
 
Vms1 directly binds ergosterol peroxide 
To determine the molecular structure of C28H44O3, we needed to purify a large 
quantity of the lipid to use in multiple analytical assays.  Since we had previously 
obtained relatively pure C28H44O3 using TLC, we decided to use silica gel flash column 
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chromatography with a similar, but more stringent solvent system to purify the species.  
We observed that as C28H44O3 is purified (Figure 3.3A), the binding affinity towards 
Vms1 increases (Figure 3.3B), further suggesting that C28H44O3 is responsible for Vms1 
binding.  We obtained a 1-H NMR of the isolated ligand (Figure 3.3C) and compared the 
peaks with known NMR spectra.  From this comparison, we determined the peaks in the 
NMR spectra of our purified ligand were identical to those of ergosterol peroxide (EP) 
(Bocking et al., 2000; Trigos and Ortega-Regules, 2002).  A comparison of our purified 
ligand and commercial EP revealed that both species possess identical retention factors 
by TLC (Figure 3.3D) and identical retention times by LC/MS (Figure 3.3E).  Lastly, our 
purified ligand and EP produced equivalent MS/MS spectra at multiple collision energies 
(data not shown).  In combination, these data argue that the lipid species we isolated, 
C28H44O3, is EP. 
We next sought to determine if EP is sufficient for Vms1 binding in vitro.  EP is 
an oxidized sterol, structurally differing from ergosterol only by the presence of an 
endoperoxide.  We demonstrated that Vms1 bound comparably to EP and the purified 
C28H44O3, while displaying no affinity towards ergosterol (Figure 3.3F).  EP is the 
product of ergosterol and ROS, specifically singlet oxygen.  Ergosterol is spontaneously 
converted to EP in vitro, by incubating singlet oxygen and ergosterol.  To create singlet 
oxygen, molecular oxygen is activated with a ROS sensitizer and ultraviolet light 
(Bocking et al., 2000).  Singlet oxygen and the conjugated 5,7-diene of ergosterol 
spontaneously cyclize, in a [4+2] Diels-Alder type cycloaddition, to generate the 5,8-
endoperoxide characteristic of EP (Figure 3.4).  EP is detected in low amounts in several 
eukaryotic species (Bocking et al., 2000; Fujimoto et al., 1994; Kahlos et al., 1989) and 
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possesses potential in various pharmaceutical applications (Bok et al., 1999; Lindequist et 
al., 1989; Nam et al., 2001); however, nothing is known regarding EP at mitochondria. 
 
Ergosterol peroxide is necessary for Vms1 
localization to mitochondria 
Since EP is produced from ergosterol and reactive oxygen, we decided to test in 
vivo Vms1 localization to mitochondria in conditions lacking these precursors.  ROS can 
be scavenged by a number of enzymes; however, the most direct way to prevent the 
formation of ROS is to starve cells of oxygen.  With the appropriate carbon source, yeast 
cells rely on fermentation, a type of anaerobic glycolysis, enabling them to grow in the 
absence of oxygen.  We observed significant reduction in Vms1MTD localization to 
mitochondria in cells grown in the absence of oxygen, known as anoxia, compared with 
cells grown in normoxia (Figure 3.5A and 3.5B).   
Ergosterol is another essential substrate for the production of EP.  Mevastatin, the 
first of a class of drugs called statins, competitively inhibits HMG CoA reductase and 
reduces sterol synthesis (Endo et al., 1976).  HMG CoA reductase is the rate-controlling 
enzyme of the mevalonate pathway, the metabolic pathway responsible for sterol 
biosynthesis.  We observed a significant reduction in Vms1MTD localization to 
mitochondria in cells that had been treated with mevastatin compared with vehicle-
treated cells (Figure 3.5C and 3.5D), suggesting that ergosterol biosynthesis is necessary 
for Vms1 localization to mitochondria.  These data argue that both reactive oxygen and 
ergosterol biosynthesis, the two species required for the formation of EP, are necessary 
for Vms1 localization to mitochondria. 
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 Because ergosterol and EP structurally differ by the presence of an endoperoxide 
on EP and display different affinities towards Vms1, we reasoned that forming the 
endoperoxide on EP would be essential for Vms1 localization.  We hypothesized that 
perturbing enzymatic steps required for the formation of the ergosterol 5,7-diene and 
subsequent endoperoxide (Figure 3.4) would significantly reduce Vms1MTD localization to 
mitochondria, while disturbing other steps would have little effect on Vms1MTD 
localization.  We identified the nonessential genes in the ergosterol biosynthetic pathway 
(Table 3.1) and measured Vms1MTD localization to mitochondria (Figure 3.6A and 3.6B) 
and mitochondrial ergosterol and EP levels (Figure 3.6C and 3.6D) in strains where each 
of these genes had been disrupted genetically.  We presume that the lipid species that 
migrate with ergosterol and EP standards in each of the mutant strains are not completely 
identical to ergosterol or EP, as each mutant strain lacks an enzyme required to 
synthesize ergosterol.  Rather, these “ergosterol” or “EP” bands in mutant strains are 
likely different in each strain, yet structurally and functionally similar to ergosterol and 
EP.  To keep things simple, we will refer to these lipids as ergosterol and EP, recognizing 
that they might have minor structural differences to lipids from wild-type (WT) cells. 
 The strength of Vms1MTD localization correlated with the levels of mitochondrial 
EP in the various strains (Figure 3.6E), suggesting that EP is required for Vms1MTD 
localization.  Vms1MTD localization and the production of EP were most affected in an 
erg3∆ mutant.  Erg3 catalyzes the formation of the 5,6-alkene (Figure 3.6F), which 
composes half of the 5,7-diene required for EP formation (Veen and Lang, 2005).  
Vms1MTD localization and mitochondrial EP levels were also affected in erg2∆, erg5∆, 
and erg24∆ mutants.  Erg2, Erg5, and Erg24 catalyze reactions at or near the formation of 
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the 5,7-diene (Figure 3.6F) (Veen and Lang, 2005).  Conversely, Vms1MTD localization 
and mitochondrial EP levels were unaffected in erg4∆, erg6∆, and atg26∆ mutants.  
These data suggest that Vms1MTD localization to mitochondria is dependent on ROS and 
ergosterol biosynthesis, specifically the steps that lead to formation of the ergosterol 5,7-
diene and subsequent endoperoxide, arguing that EP is necessary for Vms1 localization 
to mitochondria. 
 Next, we wanted to determine if EP is sufficient to promote Vms1 binding in the 
context of a lipid membrane.  To test this, we introduced EP or its precursor, ergosterol, 
into liposomes prepared from mitochondrial lipids.  We elected to use lipids obtained 
from erg2∆ cells, as this strain showed decreased Vms1MTD localization to mitochondria 
and reduced levels of EP, without grossly affecting sterol levels (Figure 3.6C).  We 
observed that addition of EP to lipids isolated from erg2∆ cells promoted a significant 
increase in Vms1 binding affinity, while the addition of ergosterol had no significant 
effect (Figure 3.7A and 3.7B).  Addition of EP to lipids isolated from WT cells had very 
little effect on Vms1 binding affinity, likely due to the EP already present in WT 
mitochondria.  Interestingly, liposomes prepared using erg3∆ mitochondrial lipids were 
difficult to form and displayed highly variable affinities to Vms1, likely due to a lack of 
ergosterol or ergosterol-like lipid (Figure 3.6C). 
 
Stress conditions enhance Vms1 affinity to mitochondria and  
increase mitochondrial ergosterol peroxide levels 
 Upon identifying a mitochondrial receptor to which Vms1 binds, we focused on 
identifying the signal that marks damaged mitochondria and promotes Vms1 recruitment.  
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We observed that mitochondria isolated from cells stressed with either rapamycin or 
H2O2 have an increased affinity towards Vms1 compared with mitochondria from 
untreated cells (Figure 3.8A and 3.8B), whereas Vms1 isolated from stressed cells has no 
change in affinity towards mitochondria compared with Vms1 isolated from unstressed 
cells (data not shown).  This suggests that stress conditions that promote Vms1 
localization affect mitochondria, and not Vms1 protein.  This is consistent with previous 
observations that Vms1 preferentially localizes to mitochondria that have been stressed 
with ROS generated by Killer Red (Heo et al., 2013). 
Since Vms1 localizes to mitochondria in response to oxidative stress (Heo et al., 
2010) and EP is a product of reactive oxygen, we speculated that EP levels might 
increase under stress conditions and mark the cellular membranes to which Vms1 
localizes.  We isolated membranes from various intracellular compartments and 
discovered that EP is specifically enriched in the mitochondria relative to other 
membranes in the cell (Figure 3.8C).  This specificity for EP at mitochondria helps 
explain why we observe Vms1 localization exclusively to mitochondria.  We determined 
that the same stress conditions that enhance mitochondrial affinity towards Vms1 cause 
an increase in the levels of mitochondrial EP (Figure 3.8D and 3.8E).  Interestingly, 
Vms1 also displayed enhanced affinity towards liposomes prepared from mitochondrial 
lipids isolated from stressed cells (Figure 3.8F and 3.8G).  The levels of EP in each stress 
condition correlated with Vms1 binding to lipids from each stress condition (Figure 
3.8H), supporting the notion that EP levels play a role regulating Vms1 binding to 




 Herein we provide compelling evidence that EP is necessary and sufficient for 
Vms1 recruitment to mitochondria.  We demonstrate that mitochondrial surface proteins 
are dispensable for Vms1 binding to mitochondria and that Vms1 binds mitochondrial 
lipid.  Following a natural products chemistry approach, we isolated a lipid species with 
the molecular formula C28H44O3, which accounted for the majority of Vms1 binding.  We 
used chromatographic, spectroscopic, and spectrometric methods to determine that 
C28H44O3 is EP.  We demonstrated that Vms1 bound equivalently to commercial EP and 
our purified C28H44O3, allowing us to conclude that the species we purified from yeast 
mitochondria, C28H44O3, is indeed EP. 
 EP is the product of ergosterol and singlet oxygen.  The 5,7 conjugated diene of 
ergosterol and singlet oxygen undergo a spontaneous Diels-Alder type cycloaddition 
reaction to produce the endoperoxide of EP (Bocking et al., 2000).  Since this reaction is 
nonenzymatic, we were unable to genetically disrupt this final step in our efforts to 
determine if EP is necessary for Vms1 localization to mitochondria.  Instead, we decided 
to reduce the levels of the EP precursors, ergosterol and reactive oxygen, and evaluate 
Vms1 localization in vivo.  Vms1 localization was dramatically reduced in cells grown in 
the absence of oxygen, suggesting that oxygen, as well as ROS, is required for Vms1 
localization to mitochondria.   
 Ergosterol biosynthesis is an essential pathway in yeast, as membranes require 
sterols.  As such, we are unable to grow cells completely devoid of sterols; however, we 
can use drugs to acutely inhibit ergosterol biosynthesis (Maciejak et al., 2013).  Statins, 
including mevastatin, are a well-characterized class of pharmaceutics that inhibit HMG 
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CoA-reductase, the enzyme responsible for the initial step of the mevalonate pathway, 
which is responsible for ergosterol biosynthesis (Tobert, 2003).  Vms1 localization was 
dramatically reduced in cells grown in the presence of mevastatin.  The dramatic 
reduction of Vms1 localization to mitochondria in conditions where the levels of the 
ergosterol and oxygen, precursors to EP, are reduced supports the hypothesis that EP is 
necessary for Vms1 localization to mitochondria.  
 EP, the receptor to which Vms1 binds, and ergosterol, a lipid with no significant 
affinity towards Vms1, differ by the presence of an endoperoxide on EP.  The production 
of this endoperoxide depends on the formation of a 5,7 diene in ergosterol.  Erg2 and 
Erg3, the enzymes required for the formation of this diene, are essential for efficient 
Vms1 localization to mitochondria, supporting the conclusion that EP, specifically the 
endoperoxide on EP, is necessary for Vms1 localization to mitochondria.  Interestingly, 
Erg5 and Erg24, enzymes that catalyze reactions away from the 5,7 diene, are both 
important for EP formation and efficient Vms1 localization to mitochondria.  While it is 
unclear why these enzymes would be required for EP biosynthesis, the observation that 
their absence leads to reduced EP levels and Vms1 localization is consistent with EP 
being required for Vms1 localization to mitochondria. 
 Demonstrating that EP is sufficient to promote Vms1 localization is more 
complex than demonstrating the necessity of EP for Vms1 localization.  Membranes are 
formed from a complex mixture of lipid molecules, where different lipid molecules are 
required to create the proper curvature and membrane architecture (Janmey and 
Kinnunen, 2006).  Because liposomes composed solely of EP do not form, we opted to 
determine if the addition of EP to liposomes was sufficient to increase Vms1 affinity.  
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The addition of EP to liposomes made from erg2∆ mitochondrial lipids strongly 
increased Vms1 binding, whereas ergosterol addition had no effect.  Addition of EP to 
liposomes prepared from WT mitochondrial lipids had little effect, likely due to levels of 
EP already present in the mitochondrial lipid isolation.  This suggests a limit to the effect 
of EP on increasing Vms1 affinity.  This is likely an in vitro effect as there is a limit in 
the amount of sterol that can be incorporated into lipid vesicles.  The ratio of sterol to 
other lipids in a membrane cannot vary dramatically without compromising the curvature 
necessary to form a vesicle.  Nevertheless, the significant increase in Vms1 affinity to 
liposomes containing added EP, compared with liposomes containing the low levels of 
endogenous EP found in erg2∆ mitochondrial lipids, is consistent with elevated EP levels 
being sufficient to promote Vms1 binding. 
 Herein we also demonstrate that EP levels increase in response to the same 
stressors that promote Vms1 binding to mitochondria in vivo and in vitro.  We previously 
showed (Heo et al., 2013) that Killer Red, a derivative of RFP that emits ROS when 
activated, induces Vms1 localization.  Interestingly, the primary ROS generated by Killer 
Red is singlet oxygen (Bulina et al., 2006), the same species responsible for the oxidation 
of ergosterol to EP.  We hypothesize that activation of mitochondrially-targeted Killer 
Red causes increased levels of mitochondrial EP, but we were unable to isolate enough 
Killer Red-damaged mitochondria to test this hypothesis.  Several reports describe 
elevated ROS levels under the stress conditions we tested, which would explain how 
more EP is produced under these stress conditions (Federico et al., 2012; Kissova et al., 
2006; Summers et al., 2014).  This increase in EP levels correlated with increased Vms1 
binding to liposomes made from mitochondrial lipids isolated from cells exposed to these 
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stressors, supporting the idea that EP is sufficient to promote Vms1 binding to 
mitochondria.   
 In this study, we observed modest but significant increases in EP levels under 
stress.  These modest increases we observe in vitro are likely dampened compared to 
what actually happens in the cell.  The mitochondrial isolation procedure is a stressful 
procedure on the cell, which has been observed to promote Vms1 localization to 
mitochondria (data not shown).  Therefore, the levels of mitochondrial EP we observe in 
untreated cells are likely elevated from their physiological levels in an unstressed cell.  
Because of the stress of the mitochondrial isolation procedure, the difference in 
mitochondrial EP levels observed between stressed and unstressed cells is likely 
dampened.  Furthermore, these same effects likely cause an increased basal level of 
binding to mitochondria, which would dampen the difference in Vms1 binding affinity 
between mitochondria from stressed and unstressed cells.  
 In multiple assays described in this study, we observed modest increases in Vms1 
binding affinity to liposomes as the EP content in these liposomes increases.  In the 
liposome flotation assay, we combine lipids from all mitochondrial membranes, not just 
the OMM.  All membrane architecture and lipid partitioning is lost in the lipid isolation 
and liposome preparation procedures.  Any local enrichment of EP, or other lipid species 
that might influence Vms1 affinity, is lost during liposome preparation.  For these 
reasons, we suggest that the physiological responses to stress might be more specific and 
effective than the modest increases in total mitochondrial EP, Vms1-mitochondrial 
comigration, and Vms1 binding to liposomes we observed. 
 Despite the inherent complications with the assays used in this study, the 
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observations we made are consistent with a model in which EP accumulation acts as a 
signal that recruits Vms1 to damaged mitochondria.  We speculate that elevated EP levels 
might contribute to disrupting the interactions between the Vms1MTD and Vms1LRS, 
possibly by promoting binding between EP and the Vms1MTD, which in turn would enable 
Vms1 to preferentially translocate to damaged mitochondria (Figure 3.9).  While this may 
be the simplest model, we must also consider that EP might not be the only receptor to 
which Vms1 binds.  Rather, EP might act as a “key” that unlocks Vms1 from its 
autoinhibited conformation to a conformation capable of binding mitochondria with 
higher affinity. In this new conformation, the Vms1MTD and Vms1LRS might be able to 
bind additional ligands or use hydrophobic surfaces to nonspecifically insert into the 
phospholipid bilayer on mitochondria.  In either instance, elevated EP levels at damaged 
mitochondria would “unlock” Vms1, and promote recruitment only to damaged 
mitochondria. 
 Contributions from ROS to a cell signaling pathway is not a novel discovery.  
Mitochondrial ROS have been described previously as contributors to a variety of cell 
signaling pathways.  In response to low oxygen levels, mitochondria release H2O2 to 
promote the expression of erythropoietin, vascular endothelial growth factor (VEGF), and 
glycolytic enzymes (Chandel et al., 1998).  Mitochondrial ROS also play a role in 
autophagy, immunity, differentiation, aging, and other adaptations to stress (Sena and 
Chandel, 2012).  Mitochondrial ROS are always present in some amount, as low levels of 
ROS are required for normal cell homeostasis.  Various stressors induce the production of 
ROS, including hypoxia, starvation, and infection.  This increase in ROS acts as a signal 
to other machinery in the cell, with the minor stress producing moderate ROS levels to 
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signal for help and extreme stress producing very high ROS levels to cause irreparable 
damage and cell death (Sena and Chandel, 2012).  
 Our observations are consistent with the notion that ROS levels and subsequent 
EP levels correlate with the severity of mitochondrial stress.  There are always some ROS 
in mitochondria, which would lead to some levels of EP always being present in 
mitochondria.  Therefore, when the Vms1MTD is expressed without the Vms1LRS, there is 
nothing to inhibit the Vms1MTD from localizing to mitochondrial EP.  Low levels of EP 
appear to be insufficient to disrupt the inhibitory interaction between the Vms1LRS and 
Vms1MTD, causing full-length Vms1 to remain in the cytosol in the absence of stress.  
However, stress conditions lead to elevated ROS levels, which oxidize ergosterol to EP.  
This increase in EP levels marks stressed mitochondria and signals for assistance from 
Vms1.  Presumably, if the mitochondrial stress is not alleviated, then ROS levels and 
subsequent EP levels will continue to rise until the organelle is “damaged beyond repair” 
and needs to be eliminated by mitophagy.  In this sense, the conversion of ergosterol to 
EP acts as an indicator of mitochondrial oxidative stress and damage. 
 This type of indicator is suggested to be a mechanism whereby chloroplast quality 
is monitored.  In plants, singlet oxygen is thought to be a specific marker for stressed 
chloroplasts.  Singlet oxygen is generated from excited chlorophyll and is the major ROS 
produced during photosynthesis.  Due to its extremely short half-life (4µs), singlet 
oxygen is confined to the organelle in which it is produced, thereby differentiating 
stressed from unstressed chloroplasts (Woodson, 2016).  It is believed that this stress is 
manifest to the rest of the cell through the oxidation of a lipid molecule by singlet 
oxygen.  Furthermore, it has been suggested that accumulation of singlet oxygen, through 
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a mechanism not yet understood, may induce ubiquitination of proteins on the chloroplast 
envelope, very similar to what we hypothesize is occurring in yeast (Woodson, 2016). 
 One interesting question arising from this study centers on the specificity of EP 
for mitochondria.  We demonstrate that EP levels are enriched in mitochondrial 
membranes compared with membranes elsewhere in the cell.  However, ROS are not 
restricted to mitochondria (Circu and Aw, 2010) and ergosterol is more abundant in other 
membranes (van Meer et al., 2008).  One study (Bocking et al., 2000) demonstrated that 
the majority of cellular EP is rapidly converted into other oxidized forms of ergosterol.  
They provide data that argue for the existence of an EP isomerase in the cell that converts 
EP into other oxidized sterols.  However, they always detected a small amount of EP that 
was never isomerized.  We demonstrate that the majority of EP in the cell is found in 
mitochondria.  It would be interesting to identify this putative EP isomerase and evaluate 
Vms1 localization in cells lacking this isomerase.  We anticipate we would see Vms1 
localize to additional membranes and possibly contribute to regulating protein quality and 
degradation in additional organelles.  
 We anticipate that this pathway through which Vms1 is recruited to mitochondria 
by an oxidized sterol is conserved in higher eukaryotes and could have implications in 
understanding physiological processes.  An oxidized sterol, signaling to promote 
mitochondrial quality control, represents a novel discovery.  Traditionally, oxidized 
sterols have been described as molecules with cytotoxic, pro-apoptotic, and pro-
inflammatory activities.  Also, oxysterol levels are elevated in pathological cells and 
tissues, such as atherosclerotic lesions, macrophage foam cells, and cataracts (Olkkonen, 
2008).  Nevertheless, recent studies have identified novel physiological functions for 
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oxidized sterols, including roles in regulating gene expression and cell signaling.  
Functions for oxysterols have been described in steroid hormone synthesis, lipid 
metabolism, modulating estrogen receptor function, embryonic development, and cell 
differentiation (Olkkonen, 2008).  With the data presented in this study, we add that 




Yeast strains, media, and growth conditions 
Saccharomyces cerevisiae strain JRY2509 (MATa his3 leu2 ura3 met15) was 
used as the WT strain.  Deletion mutant strains were taken from the Saccharomyces 
Genome Deletion Project.  Complete strain information is given in Table 3.1.  Yeast were 
transformed by the lithium acetate method, and grown at 30°C in SD medium (0.67% 
yeast nitrogen base, 2% glucose) with amino acids unless otherwise indicated (Sherman, 
1991).  To test the effect of stress on Vms1-mitochondria comigration, WT cells 
transformed with empty vector were grown to mid-log phase in SD-Ura medium and 
treated with one of the following prior to harvesting: 200ng/mL rapamycin (LC 
Laboratory #r-5000) for 2.5 hours, 3mM H2O2 (Millipore #386790) for 90 minutes, or 
10µM CCCP (VWR International #215911) for 2.5 hours. 
 
Plasmids 
A plasmid (pJR132011A) expressing C-terminally GFP-tagged Vms1MTD was 
generated by PCR amplifying the VMS1 coding region from nucleotide 544 to 1251 and 
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the VMS1 promoter from 335 nucleotides upstream to the VMS1 start codon from 
genomic DNA and ligating them in frame into a pRS416-based vector containing a GFP 
tag (pJR1415A).  Mitochondria were identified with a plasmid (pJR9509B) encoding 
RFP targeted to the mitochondria as described previously (Heo et al., 2010).  
 
Mitochondria purification 
Cells were exposed to the indicated conditions and harvested in mid-log phase.  
Mitochondria were then purified by sucrose gradient ultracentrifugation as previously 
described (Hao et al., 2009). 
 
Lipid isolation and alkaline hydrolysis 
Lipids were isolated from mitochondria, post-mitochondrial supernatant (PMS), 
or whole cell extract (WCE) using a modified Folch extraction.  Pelleted mitochondria 
(1-5mg as measured by protein concentration) were resuspended in 500µL of PBS 
(Gibco).  500µL of methanol (Sigma) and 1mL of chloroform (Fischer Scientific) were 
added to 500µL of WCE, PMS, or resuspended mitochondria and vortexed at high speed 
for 10 minutes.  The resulting mixture was then centrifuged for 2 minutes at 1000xg.  The 
lower organic phase was transferred to a new tube and the remaining aqueous phase was 
extracted with chloroform two additional times.  The pooled organic extracts were then 
washed two times with water.  The washed organic extract was then evaporated by 
SpeedVac (Savant) to yield a lipid film.  This lipid film was then analyzed as a total lipid 
fraction or subjected to NaOH hydrolysis as previously described (Guan et al., 2010) to 
create an alkaline-resistant lipid fraction enriched for sterols, and sphingolipids. 
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Proteinase K treatment 
Purified mitochondria were resuspended in SEM buffer (250mM sucrose, 10mM 
MOPS, 1mM EDTA, pH 7.2) to a concentration of 5mg/mL.  1µL of Proteinase K (New 
England BioLabs #P8107S) for every 50µg of mitochondria was then added.  The 
mixture was then quickly mixed and incubated on ice for 30 minutes.  1µL of 25mg/mL 
PMSF (in isopropanol) was added for every 50µg of mitochondria and the resulting 
mixture was centrifuged at 3000xg for 5 minutes and the supernatant was discarded.  The 
mixture was washed with 250µL SEM buffer, centrifuged at 3000xg for 5 minutes, and 
the supernatant was discarded again.  To test the efficiency of protein cleavage at the 
OMM, untreated and proteinase K-treated mitochondria were subjected to SDS-PAGE 
and Western blot for Fzo1 (Dr. Janet Shaw), Tom22 (Dr. Kostas Tokatlidis), Por1 
(Abcam #110326), Mia40 (Dr. Kostas Tokatlidis), Sdh1 (21st Century Biochemicals 
#Pr1852a), and Sdh2 (21st Century Biochemicals #Pr1633). 
 
Mitochondrial comigration assay 
100µg of purified mitochondria were incubated with 2.5µg of purified 
recombinant 10XHis-Vms11-417-HA in 300µL of SEM buffer for 1 hour at 4˚C.  30µL was 
taken as an input control and the remaining mixture was loaded on a step-sucrose 
gradient (60%, 32%, 23%, 15% sucrose in MOPS buffer) and mitochondria-bound Vms1 
was separated from unbound Vms1 by high speed ultracentrifugation as previously 
described (Meisinger et al., 2000).  After centrifugation, fractions were collected, TCA 
precipitated, and subjected to SDS-PAGE and Western blot with α-His6 (Clontech 
#631212) and α-Por1 (Abcam #110326) antibodies. 
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LC/MS analysis 
Samples are resuspended in 25 µL of IPA:water:ACN (72:16:12) in 10 mM 
ammonium formate and 0.1% formic acid and centrifuged for 5 minutes at 15,000xg.  
The supernatant is then transferred to a LC/MS vial with insert.  Lipid extracts are 
separated on an Acquity UPLC CSH C18 1.7 µm 2.1 x 100 mm column maintained at 
60°C connected to an Agilent HiP 1290 Sampler, Agilent 1290 Infinity pump, equipped 
with an Agilent 1290 Flex Cube and Agilent 6520 Accurate Mass Q-TOF dual ESI mass 
spectrometer.  The source gas temperature is set to 350 °C, with a gas flow of 11.1 
(L/min) and a nebulizer pressure of 24 psig. VCap voltage is set at 5000 V, fragmentor at 
250 V, skimmer at 74.4 V, and Octopole RF peak at 750 V.  Reference masses (m/z 
121.0509 and 922.0098) are infused with nebulizer pressure at 2 psig and acquired with 
the scan range between m/z 100 – 1700 in positive mode.  Mobile phase A consists of 
ACN:water (60:40 v/v) in 10 mM ammonium formate and 0.1% formic acid, and mobile 
phase B consists of IPA:water (90:10 v/v) in 10 mM ammonium formate and 0.1% 
formic acid.  The chromatography gradient starts at 15% mobile phase B then increases 
to 30% B over 4 minutes, it then increases to 52% B from 4-5 minutes, then increases to 
82% B from 5-22 minutes, then increases to 95% B from 22-23 minutes, then increases to 
99% B from 23-27 minutes.  From 27-38 minutes it is held at 99%B, then decreases to 
15% B from 38-38.2 minutes and is held there from 38.2-44 minutes.  Flow is 0.3 
mL/min throughout.  Injection volume is 20 µL for fractionation experiments and 3µL for 
analytical experiments.  Using an in-line splitter, post-column flow is diverted at a 10:1 
ratio to the BioRad 2110 fraction collector collecting 1 minute fractions (0.3 mL per 
fraction).  Tandem mass spectrometry was conducted with the same LC gradient and 
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source conditions using collision energies of 10 V, 20 V, and 40 V. 
 
Thin-layer chromatography (TLC) separation and orcinol stain 
Lipids were dissolved in 1:1 chloroform:methanol and spotted on to TLC plates 
(EMD Millipore #1.05554.0001).  The TLC was resolved in a 40:1 chloroform:methanol 
solvent system.  Lipids were extracted from TLC plates by vortexing the strip of TLC 
plate in a 1:1 chloroform:methanol mixture for 10 minutes.  The TLC strip was removed 
and the mixture was centrifuged for 2 minutes at high speed to pellet the loose silica.  The 
supernatant was transferred to a fresh tube and the resulting organic solution was 
evaporated by SpeedVac (Savant), yielding a lipid film.  TLC plates were stained with an 
orcinol solution.  200mg of orcinol (Sigma) were dissolved in 11.4mL of H2SO4 and 
brought up to 100mL with water.  Resolved TLC plates were submerged briefly in the 




Starting from the bottom, a classic preparative chromatography column (with 
solvent reservoir) was prepared with a glass wool plug, washed sand (Fisher Scientific), 
silica gel (VWR International #SX0143U-1) at a ratio of 50:1 silica mass:sample mass 
that had been suspended in hexane (Sigma), and another layer of washed sand on top.  
The hexane was drained from the column and the lipid mixture, resuspended in hexane, 
was loaded slowly on to the column and allowed to migrate through the sand into the 
silica gel layer.  Lipids were then eluted with the following solvent system: 1 column 
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volume hexane (Sigma), 2 column volumes dichloromethane (Fischer Scientific), 2 
column volumes of 1:1 dichloromethane:chloroform (Fischer Scientific), and then 
chloroform until the desired C28H44O3 had completely eluted as monitored by TLC.   
 
NMR 
1-H NMR spectra were acquired with CDCl3 as the solvent on a Varian Inova 
500 MHz NMR spectrometer in the University of Utah NMR Core. 
 
Lipid blot 
1µL of a lipid solution, containing lipids purified from yeast, EP (Chemfaces 
#CFN98035), or ergosterol (Fischer Scientific #AC11781), in 100% chloroform was 
spotted on to nitrocellulose membrane (Fischer Scientific #10600002).  The membrane 
was then blocked with 3% fatty-acid free BSA (Sigma #A6003) in TBS (25mM Tris, 
150mM NaCl, pH 7.5) for 1 hour at room temperature.  The blocking solution was then 
replaced with a 1µg/mL solution of 10XHis-Vms11-417-HA in TBS with 3% fatty-acid free 
BSA and incubated overnight at 4˚C.  The membrane was then subjected to standard 
Western blot techniques with 1˚ and 2˚ antibody incubation in TBS with 3% fatty-acid 
free BSA to visualize protein-lipid binding. 
 
Liposome preparation 
A control lipid solution was prepared by mixing 0.82 molar equivalents of DOPC 
(Avanti #850375P) and 0.18 molar equivalents of cholesterol (Avanti #700000P) in a 
glass vial.  Additional lipids were added to the control liposome solution where indicated.  
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Solvent was evaporated by gentle vortexing under a steady stream of argon gas to make a 
lipid film around the walls of the vial.  These films were dried under vacuum for 1 hour 
at -52˚C.  The lipid film was then resolubilized in hexane (Sigma) and subsequently 
evaporated under a gentle stream of argon while vortexing, followed by a second round 
of vacuum-drying for 3 to 4 hours at -52˚C.  Lipid films were then hydrated with TBS to 
produce a 1mg lipid/mL buffer mixture.  This mixture was rotated overnight at 4˚C and 
then extruded through 1.0µM membranes (Fischer Scientific #05-71-5120) to produce a 
semi-homogenous liposome population.  Aliquots were stored at -80˚C.  Liposomes 
prepared from total mitochondrial lipids were prepared without the addition of DOPC and 
cholesterol.  Total mitochondrial lipids isolated from the indicated strains and additional 
lipids, if indicated, were mixed and dissolved in chloroform.  Liposomes were prepared 
from this lipid solution as described above. 
 
Liposome flotation assay 
100µL of liposomes were incubated with 2.5µg of purified 10XHis-Vms11-417-HA 
at 4˚C for 1 hour.  10µL of the mixture was taken as an input control.  300µL of 2M 
sucrose in TBS was added to the liposome-protein mixture and mixed well.  A step-
sucrose gradient was then created by gently loading 300µL of 1M sucrose in TBS on top 
of the liposome mixture, followed by 300µL of 0.5M sucrose in TBS, and finally 75µL of 
TBS.  This was spun for 30 minutes in a Beckman Optima-Max table-top ultracentrifuge 
at 55,000rpm allowing the liposomes to float to the top of the gradient, thereby separating 
unbound protein from liposome-bound protein (Koirala et al., 2013).  150µL was taken 
from the top (bound Vms1) and bottom (unbound Vms1) of the sucrose gradient and 
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analyzed by SDS-PAGE and Western blot with α-His6 antibody (Clontech #631212). 
 
Microscopy 
The WT (JRY2509) or mutant strains were transformed with a plasmid expressing 
Vms1MTD -GFP under the native VMS1 promoter and a plasmid expressing 
mitochondrially-targeted RFP.  The cells were grown to mid-log phase and then imaged 
using a Zeiss Axioplan 2 Imaging microscope (Carl Zeiss).  To test the effect of statin-
treatment on Vms1MTD localization, WT cells transformed with a plasmid expressing 
Vms1MTD -GFP under the native VMS1 promoter and a plasmid expressing 
mitochondrially-targeted RFP were inoculated, back-diluted, and grown in media 
containing vehicle or 500µM mevastatin (Santa Cruz Biotech #SC-200853A) for 24 
hours prior to imaging.  To test the dependence of Vms1 lipid receptor production on the 
presence of oxygen, WT (JRY2509) cells were transformed with a plasmid expressing 
Vms1MTD -GFP under the native VMS1 promoter and a plasmid expressing 
mitochondrially-targeted RFP.  After reaching mid-log phase, these cells were then 
grown for 6 hours either in anoxia with or without supplemented ergosterol (20µg/mL) 
and fatty acids (5mg/mL Tween 80) or normoxia with or without supplemented 
ergosterol and fatty acids (Reiner et al., 2006).  After the 6 hour treatment, cells were 
imaged as described previously. 
 
Quantitation methods 
All Western blots were quantitated using ImageJ 1.50i software.  Microscopy was 
quantified as the mean GFP intensity (Vms1MTD-GFP) in pixels containing RFP signal 
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(mitochondria).  All statistics are derived from the comparison of the mean in each 
experimental condition to the WT or control sample utilizing an unpaired t-test, unless 
specifically indicated otherwise. 
 
References 
Ayala, A., Munoz, M.F., and Arguelles, S. (2014). Lipid peroxidation: production, 
metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. 
Oxid Med Cell Longev 2014, 360438. 
Balch, W.E., Morimoto, R.I., Dillin, A., and Kelly, J.W. (2008). Adapting proteostasis 
for disease intervention. Science 319, 916-919. 
Bocking, T., Barrow, K.D., Netting, A.G., Chilcott, T.C., Coster, H.G., and Hofer, M. 
(2000). Effects of singlet oxygen on membrane sterols in the yeast Saccharomyces 
cerevisiae. Eur J Biochem 267, 1607-1618. 
Bohovych, I., Kastora, S., Christianson, S., Topil, D., Kim, H., Fangman, T., Zhou, Y.J., 
Barrientos, A., Lee, J., Brown, A.J., et al. (2016). Oma1 links mitochondrial protein 
quality control and TOR signaling to modulate physiological plasticity and cellular stress 
responses. Mol Cell Biol 36, 2300-2312. 
Bok, J.W., Lermer, L., Chilton, J., Klingeman, H.G., and Towers, G.H. (1999). 
Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 51, 891-898. 
Bulina, M.E., Chudakov, D.M., Britanova, O.V., Yanushevich, Y.G., Staroverov, D.B., 
Chepurnykh, T.V., Merzlyak, E.M., Shkrob, M.A., Lukyanov, S., and Lukyanov, K.A. 
(2006). A genetically encoded photosensitizer. Nat Biotechnol 24, 95-99. 
Calvo, S.E., and Mootha, V.K. (2010). The mitochondrial proteome and human disease. 
Annu Rev Genomics Hum Genet 11, 25-44. 
Chandel, N.S., Maltepe, E., Goldwasser, E., Mathieu, C.E., Simon, M.C., and 
Schumacker, P.T. (1998). Mitochondrial reactive oxygen species trigger hypoxia-induced 
transcription. Proc Natl Acad Sci U S A 95, 11715-11720. 
Circu, M.L., and Aw, T.Y. (2010). Reactive oxygen species, cellular redox systems, and 
apoptosis. Free Radic Biol Med 48, 749-762. 
Costa, V., Quintanilha, A., and Moradas-Ferreira, P. (2007). Protein oxidation, repair 
mechanisms and proteolysis in Saccharomyces cerevisiae. IUBMB Life 59, 293-298. 
Endo, A., Kuroda, M., and Tsujita, Y. (1976). ML-236A, ML-236B, and ML-236C, new 
58
inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot (Tokyo) 29, 
1346-1348. 
Federico, A., Cardaioli, E., Da Pozzo, P., Formichi, P., Gallus, G.N., and Radi, E. (2012). 
Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 322, 254-262. 
Fujimoto, H., Nakayama, M., Nakayama, Y., and Yamazaki, M. (1994). Isolation and 
characterization of immunosuppressive components of three mushrooms, Pisolithus 
tinctorius, Microporus flabelliformis and Lenzites betulina. Chem Pharm Bull (Tokyo) 
42, 694-697. 
Giaever, G., Chu, A.M., Ni, L., Connelly, C., Riles, L., Veronneau, S., Dow, S., Lucau-
Danila, A., Anderson, K., Andre, B., et al. (2002). Functional profiling of the 
Saccharomyces cerevisiae genome. Nature 418, 387-391. 
Guan, X.L., Riezman, I., Wenk, M.R., and Riezman, H. (2010). Yeast lipid analysis and 
quantification by mass spectrometry. Methods Enzymol 470, 369-391. 
Hao, H.X., Khalimonchuk, O., Schraders, M., Dephoure, N., Bayley, J.P., Kunst, H., 
Devilee, P., Cremers, C.W., Schiffman, J.D., Bentz, B.G., et al. (2009). SDH5, a gene 
required for flavination of succinate dehydrogenase, is mutated in paraganglioma. 
Science 325, 1139-1142. 
Heo, J.M., Livnat-Levanon, N., Taylor, E.B., Jones, K.T., Dephoure, N., Ring, J., Xie, J., 
Brodsky, J.L., Madeo, F., Gygi, S.P., et al. (2010). A stress-responsive system for 
mitochondrial protein degradation. Mol Cell 40, 465-480. 
Heo, J.M., Nielson, J.R., Dephoure, N., Gygi, S.P., and Rutter, J. (2013). Intramolecular 
interactions control Vms1 translocation to damaged mitochondria. Mol Biol Cell 24, 
1263-1273. 
Heo, J.M., and Rutter, J. (2011). Ubiquitin-dependent mitochondrial protein degradation. 
Int J Biochem Cell Biol 43, 1422-1426. 
Janmey, P.A., and Kinnunen, P.K. (2006). Biophysical properties of lipids and dynamic 
membranes. Trends Cell Biol 16, 538-546. 
Kahlos, K., Kangas, L., and Hiltunen, R. (1989). Ergosterol peroxide, an active 
compound from Inonotus radiatus. Planta Med 55, 389-390. 
Kissova, I., Deffieu, M., Samokhvalov, V., Velours, G., Bessoule, J.J., Manon, S., and 
Camougrand, N. (2006). Lipid oxidation and autophagy in yeast. Free Radic Biol Med 
41, 1655-1661. 
Koirala, S., Guo, Q., Kalia, R., Bui, H.T., Eckert, D.M., Frost, A., and Shaw, J.M. (2013). 
Interchangeable adaptors regulate mitochondrial dynamin assembly for membrane 
scission. Proc Natl Acad Sci U S A 110, E1342-1351. 
59
Lin, M.T., and Beal, M.F. (2006). Mitochondrial dysfunction and oxidative stress in 
neurodegenerative diseases. Nature 443, 787-795. 
Lindequist, U., Lesnau, A., Teuscher, E., and Pilgrim, H. (1989). [The antiviral action of 
ergosterol peroxide]. Pharmazie 44, 579-580. 
Livnat-Levanon, N., and Glickman, M.H. (2011). Ubiquitin-proteasome system and 
mitochondria - reciprocity. Biochim Biophys Acta 1809, 80-87. 
Maciejak, A., Leszczynska, A., Warchol, I., Gora, M., Kaminska, J., Plochocka, D., 
Wysocka-Kapcinska, M., Tulacz, D., Siedlecka, J., Swiezewska, E., et al. (2013). The 
effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing 
human HMG-CoA reductase. BMC Biotechnol 13, 68. 
Martinelli, P., and Rugarli, E.I. (2010). Emerging roles of mitochondrial proteases in 
neurodegeneration. Biochim Biophys Acta 1797, 1-10. 
Meisinger, C., Sommer, T., and Pfanner, N. (2000). Purification of Saccharomcyes 
cerevisiae mitochondria devoid of microsomal and cytosolic contaminations. Anal 
Biochem 287, 339-342. 
Murphy, M.P. (2009). How mitochondria produce reactive oxygen species. Biochem J 
417, 1-13. 
Nam, K.S., Jo, Y.S., Kim, Y.H., Hyun, J.W., and Kim, H.W. (2001). Cytotoxic activities 
of acetoxyscirpenediol and ergosterol peroxide from Paecilomyces tenuipes. Life Sci 69, 
229-237. 
Ni, H.M., Williams, J.A., and Ding, W.X. (2015). Mitochondrial dynamics and 
mitochondrial quality control. Redox Biol 4, 6-13. 
Niki, E., Yoshida, Y., Saito, Y., and Noguchi, N. (2005). Lipid peroxidation: 
mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun 338, 668-
676. 
Olkkonen, V.M. (2008). New functions for oxysterols and their cellular receptors. Lipids 
Insights 2, 1-9. 
Powers, E.T., Morimoto, R.I., Dillin, A., Kelly, J.W., and Balch, W.E. (2009). Biological 
and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 78, 
959-991. 
Reiner, S., Micolod, D., Zellnig, G., and Schneiter, R. (2006). A genomewide screen 
reveals a role of mitochondria in anaerobic uptake of sterols in yeast. Mol Biol Cell 17, 
90-103. 
Schuberth, C., Richly, H., Rumpf, S., and Buchberger, A. (2004). Shp1 and Ubx2 are 
60
adaptors of Cdc48 involved in ubiquitin-dependent protein degradation. EMBO Rep 5, 
818-824. 
Sena, L.A., and Chandel, N.S. (2012). Physiological roles of mitochondrial reactive 
oxygen species. Mol Cell 48, 158-167. 
Sherman, F. (1991). Getting started with yeast. Methods Enzymol 194, 3-21. 
Summers, D.W., DiAntonio, A., and Milbrandt, J. (2014). Mitochondrial dysfunction 
induces Sarm1-dependent cell death in sensory neurons. J Neurosci 34, 9338-9350. 
Tobert, J.A. (2003). Lovastatin and beyond: the history of the HMG-CoA reductase 
inhibitors. Nat Rev Drug Discov 2, 517-526. 
Trigos, A., and Ortega-Regules, A. (2002). Selective destruction of microscopic fungi 
through photo-oxidation of ergosterol. Mycologia 94, 563-568. 
Tsuboi, H., Kouda, K., Takeuchi, H., Takigawa, M., Masamoto, Y., Takeuchi, M., and 
Ochi, H. (1998). 8-hydroxydeoxyguanosine in urine as an index of oxidative damage to 
DNA in the evaluation of atopic dermatitis. Br J Dermatol 138, 1033-1035. 
van Meer, G., Voelker, D.R., and Feigenson, G.W. (2008). Membrane lipids: where they 
are and how they behave. Nat Rev Mol Cell Biol 9, 112-124. 
Veen, M., and Lang, C. (2005). Interactions of the ergosterol biosynthetic pathway with 
other lipid pathways. Biochem Soc Trans 33, 1178-1181. 
Woodson, J.D. (2016). Chloroplast quality control - balancing energy production and 
stress. New Phytol 212, 36-41. 
Ye, Y., Meyer, H.H., and Rapoport, T.A. (2003). Function of the p97-Ufd1-Npl4 
complex in retrotranslocation from the ER to the cytosol: dual recognition of 
nonubiquitinated polypeptide segments and polyubiquitin chains. J Cell Biol 162, 71-84. 
Youle, R.J., and Narendra, D.P. (2011). Mechanisms of mitophagy. Nat Rev Mol Cell 
Biol 12, 9-14. 
Zinser, E., Sperka-Gottlieb, C.D., Fasch, E.V., Kohlwein, S.D., Paltauf, F., and Daum, G. 
(1991). Phospholipid synthesis and lipid composition of subcellular membranes in the 




Figure 3.1.  Vms1 binding to mitochondria is not dependent on mitochondrial 
surface proteins. 
A. Mitochondria were either left untreated or treated with proteinase K as described. 
Proteins from various mitochondrial compartments were analyzed by SDS-PAGE and 
Western blot.  20µg of mitochondrial protein loaded.  B. Purified 10XHis-Vms11-417-HA 
and untreated or proteinase K-treated mitochondria were mixed and subjected to the 
sucrose gradient centrifugation as described.  C. Comigration was quantitated as the ratio 
of Vms1 to Por1 over at least 5 experiments in each condition.  Data represented as the 












































Figure 3.2.  Vms1 binds a lipid with molecular formula C28H44O3. 
A. Control liposomes, liposomes containing total mitochondrial lipids (total lipids from 
1mg of mitochondria per 100µL liposomes), or liposomes containing alkaline-resistant 
mitochondrial lipids (alkaline-resistant lipids from 1mg of mitochondria per 100µL 
liposomes) were subjected to the flotation assay as described.  B. Mitochondrial alkaline-
resistant lipids were fractionated by UPLC as described. Lipids from 5 adjacent fractions 
were combined to create pooled fractions. Lipids from each pooled fraction were 
incorporated into liposomes (lipids from 2mg mitochondria per 100µL liposomes) and 
subjected to the flotation assay as described.  C. Lipids from each individual fraction 
composing “pooled fraction 2” were incorporated into liposomes (lipids from 1mg 
mitochondria per 100µL liposomes) and subjected to the flotation assay as described.   
D. Mitochondrial alkaline-resistant lipids were separated into 5 fractions by TLC (40:1 
chloroform:methanol).  Lipids isolated from each fraction were incorporated into 
liposomes (lipids from 1mg mitochondria per 100µL liposomes) and subjected to the 
flotation assay as described.  E. Lipids from the 5 UPLC fractions in C and the 5 TLC 
fractions in D were analyzed by TLC (40:1 chloroform:methanol) and orcinol stain.  The 
















































Figure 3.3.  The lipid species, C28H44O3, is ergosterol peroxide and binds Vms1 
directly. 
A. The species with formula C28H44O3, indicated by a red star, was isolated from a 
mixture of mitochondrial alkaline-resistant lipids by silica chromatography as described.  
B. Liposomes containing the silica chromatography input or the isolated C28H44O3 species 
were prepared such that they had equivalent amounts of C28H44O3 (lipids from 
approximately 1mg mitochondria per 100µL liposomes). These liposomes and control 
liposomes were subjected to the flotation assay as described.  C. 1-H NMR of the isolated 
C28H44O3 was performed as described.  D. The isolated C28H44O3 species and purified 
ergosterol peroxide were compared by TLC (40:1 chloroform:methanol) and orcinol stain.   
E. The isolated C28H44O3 species and purified ergosterol peroxide were analyzed by 
LC/MS as described.  F. Nitrocellulose membranes were spotted with equivalent amounts 
(5µg and 1.67µg) of isolated C28H44O3, ergosterol peroxide, or ergosterol and subjected to 
lipid blot analysis as described. 	
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Figure 3.4.  Ergosterol carbon numbering scheme relative to ergosterol peroxide. 






Figure 3.5.  Ergosterol peroxide is necessary for Vms1 localization to mitochondria. 
A. WT cells transformed with a plasmid expressing Vms1MTD-GFP under the native 
VMS1 promoter and a plasmid expressing mitochondrially-targeted RFP were grown for 
6 hours in anoxia or normoxia and subjected to fluorescence microscopy. Representative 
images are shown. B. The mitochondrial MTD intensity was quantified as described for 
100+ cells in each condition.  Data represented as mean ± SEM.  ***p≤0.001 C. WT cells 
transformed with a plasmid expressing Vms1MTD-GFP under the native VMS1 promoter 
and a plasmid expressing mitochondrially-targeted RFP were grown in the presence of 
500µM mevastatin or vehicle for 24 hours and subjected to fluorescence microscopy.  
Representative images are shown.  D. The mitochondrial Vms1MTD intensity was 
quantified as described for 100+ cells in each condition.  Data represented as mean ± 
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Figure 3.6.  Some steps in ergosterol synthesis are required for Vms1 localization 
and ergosterol peroxide production. 
A. WT and the indicated genetic mutants were transformed with a plasmid expressing 
Vms1MTD-GFP under the native VMS1 promoter and a plasmid expressing 
mitochondrially-targeted RFP. They were grown to mid-log phase and subjected to 
fluorescence microscopy. Representative images shown.  B. The mitochondrial Vms1MTD 
intensity was quantified as described for 500+ cells.  Data represented as mean ± SEM.  
***p≤0.001  C. 20µg of purified mitochondria (by protein concentration) from the 
indicated strains were analyzed by SDS-PAGE and Western blot for Por1 as a loading 
control. Lipids from 2mg of mitochondria from each strain were isolated as described and 
analyzed by TLC (40:1 chloroform: methanol) and orcinol stain.  D. Ergosterol peroxide 
from C was quantitated as the ratio of ergosterol peroxide to Por1 over 3 experiments.  
Data represented as mean ± SEM.  *p≤0.05, **p≤0.01, ***p≤0.001  E. Vms1 localization 
to mitochondria from B and ergosterol peroxide levels from D were correlated across the 
various strains.  F. Vms1 localization to mitochondria is reduced when the enzymes and 
bonds marked in orange are affected.  Vms1 localization to mitochondria is unaffected 
when the enzymes and bonds marked in blue are affected. 
 





















































































































Figure 3.7.  Ergosterol peroxide addition enhances Vms1 binding to liposomes. 
A. No additional lipids, 3.75µg ergosterol, or 3.75µg ergosterol peroxide were added to 
mitochondrial lipids isolated from 300µg of WT or ∆erg2 cells to make liposomes as 
described.  These liposomes were then subjected to the flotation assay as described.  B. 
Vms1 binding to liposomes from A was quantified as the ratio of bound Vms1 to input 
Vms1, relative to liposomes containing no added lipids.  Data represented as mean ± 




























































Figure 3.8.  Stress conditions that promote Vms1 binding to mitochondria increase 
mitochondrial ergosterol peroxide levels. 
A. Purified 10XHis-Vms11-417-HA and mitochondria isolated from indicated treatments 
were subjected to sucrose gradient centrifugation.  B. Comigration was quantitated as the 
ratio of Vms1 to Por1 over at least 4 experiments.  Data represented as mean ± SEM.  
**p≤0.01, ***p≤0.001  C. Ergosterol peroxide from various subcellular fractions was 
quantitated as the ratio of ergosterol peroxide to ergosterol over at least 3 experiments.  
Data represented as mean ± SEM.  **p≤0.01  D. 20µg of mitochondria from the indicated 
treatments were analyzed by Western blot for Por1 as a loading control. Lipids from 2mg 
of mitochondria from each strain were isolated and analyzed by TLC and orcinol stain.  
E. Ergosterol peroxide was quantitated as the ratio of ergosterol peroxide to Por1 over at 
least 3 experiments.  Data represented as mean ± SEM.  *p≤0.05, ***p≤0.001  F. 100µg 
of mitochondrial lipids isolated from the indicated treatments were used to make 
liposomes and subjected to the flotation assay.  G. Vms1 binding to liposomes was 
quantified as the ratio of bound Vms1 to input over at least 4 experiments.  Data 
represented as mean ± SEM.  *p≤0.05  H. Vms1 binding to liposomes from G and 
















































































































































Figure 3.9.  A model of stress-responsive EP accumulation and Vms1 localization. 
Low levels of EP, the receptor to which the Vms1MTD binds, are present on mitochondria 
under unstressed conditions.  The low levels of mitochondrial EP are insufficient to 
disrupt the interaction between the Vms1LRS and Vms1MTD, which sequesters Vms1 in the 
cytosol.  Stress conditions promote the production of reactive oxygen species, which 
leads to an increase in the levels of mitochondrial EP.  This increase in EP levels on 
stressed mitochondria contributes to disrupting the interactions between the Vms1LRS and 
Vms1MTD, possibly by promoting competing interactions between EP and the Vms1MTD, 


















Table 3.1.  Strains used in this study. 
Strain Genotype Source 
JRY2509 (BY4741) MATa his3 leu2 ura3 met15 
  
This study 
erg2∆ (BY4741) MATa his3 leu2 ura3 met15 
erg2::kanMX 
(Giaever et al., 2002) 
erg3∆ (BY4741) MATa his3 leu2 ura3 met15 
erg3::kanMX 
(Giaever et al., 2002) 
erg4∆ (BY4741) MATa his3 leu2 ura3 met15 
erg4::kanMX 
(Giaever et al., 2002) 
erg5∆ (BY4741) MATa his3 leu2 ura3 met15 
erg5::kanMX 
(Giaever et al., 2002) 
erg6∆ (BY4741) MATa his3 leu2 ura3 met15 
erg6::kanMX 
(Giaever et al., 2002) 
erg24∆ (BY4741) MATa his3 leu2 ura3 met15 
erg24::kanMX 
(Giaever et al., 2002) 
atg26∆ (BY4741) MATa his3 leu2 ura3 met15 
atg26::kanMX 




SPHINGOLIPIDS CONTRIBUTE TO VMS1 
TRANSLOCATION TO MITOCHONDRIA 
Summary 
Mitochondrial dysfunction contributes to a variety of human diseases.  Cells have 
developed a network of mitochondrial quality control pathways.  A critical component of 
one of these pathways is the Vms1-Cdc48 protein complex, which translocates to 
damaged mitochondria under stress and aids in the proteasome-dependent degradation of 
mitochondrial proteins.  Mitochondrial targeting of this complex is regulated by Vms1, 
through a conserved Mitochondrial Targeting Domain (Vms1MTD), which is directly 
inhibited by intramolecular interactions with an N-terminal Leucine Rich Sequence 
(Vms1LRS) under unstressed conditions.  Under stressed conditions, this inhibition is 
relieved through an uncharacterized mechanism, enabling Vms1 to localize to 
mitochondria.  We have determined that mitochondrial sphingolipids are necessary to 
facilitate Vms1 localization to mitochondria, although we have not identified endogenous 
sphingolipid species to which Vms1 directly binds in the cell.  These data support a 
model in which sphingolipids are required to create membrane regions with unique 
biophysical properties that enable Vms1 to bind its receptor, ergosterol peroxide. 
 
Introduction 
The need for mitochondrial quality control 
Mitochondria are dynamic and complex organelles that are critical for a variety of 
cellular functions, including ATP generation, iron metabolism, calcium signaling, and 
more (Calvo and Mootha, 2010).  Consistent with their essential roles in diverse cellular 
functions, mitochondrial dysfunction can cause a wide range of diseases, including 
metabolic disorders, neurodegenerative disease, cardiovascular disease, and cancer (Lin 
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and Beal, 2006).   
To maintain mitochondrial quality, cells have developed a network of pathways 
responsible for eliminating dysfunctional organelles and disposing of misfolded and 
damaged proteins (Tatsuta, 2009).  One of these systems is selective autophagy of 
mitochondria organelles, or mitophagy.  In the process of mitophagy, damaged organelles 
are marked with ubiquitin to target them for engulfment in double-membraned vesicles.  
These vesicles are then degraded in the highly acidic lysosomal environment (Youle and 
Narendra, 2011).   
Mitochondria are also capable of degrading proteins without eliminating entire 
organelles, a process far less energetically expensive to the cell.  One system utilizes 
proteases found in the various intramitochondrial compartments of eukaryotic cells, 
which are responsible for degrading components of the electron transport chain 
(Bohovych et al., 2015; Quiros 2015).  Through another pathway, vesicles containing 
oxidized proteins bud off of damaged mitochondria and are transported to the lysosome, 
independent of canonical autophagy machinery, where the contents are then degraded (Ni 
et al., 2015).  Another system responsible for the degradation of a subset of mitochondrial 
proteins is the ubiquitin-proteasome system (UPS).  One feature of the UPS is the 
recruitment of the AAA-ATPase Cdc48 to various organelles by multiple adaptor 
proteins.  Upon recruitment to the specific organelle, this AAA-ATPase extracts 
ubiquitinated proteins and sends them for degradation by the proteasome (Ross et al., 
2015; Taylor and Rutter, 2011).  We recently discovered a novel Cdc48 adaptor that 
recruits Cdc48 specifically to mitochondria, called Vms1 (Heo et al., 2010). 
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The relationship between mitochondria and sphingolipids 
Sphingolipids are a unique class of lipids, characterized by the presence of a 
sphingoid base.  In addition to serving as essential structural components of membranes, 
sphingolipids fulfill a role as signaling molecules in various cellular processes, including 
cell growth, apoptosis, inflammation, and proliferation (Spincemaille et al., 2014).  
Sphingolipid synthesis is a highly conserved biosynthetic process in eukaryotes (Liu et 
al., 2014).  Serine-palmitoyl transferase (SPT) catalyzes the first step of de novo 
sphingolipid synthesis, the condensation of serine and palmitoyl coenzyme A to create 3-
ketodihydrosphingosine (3-keto DHS).  Dihydrosphingosine (DHS), formed from the 
reduction of 3-keto DHS, can be acylated to create various species of dihydroceramide, 
where the chain length of the fatty acid added to DHS characterizes each species.  
Additional reactions, such as hydroxylation, phosphorylation, and glycosylation, can 
convert these precursor molecules into more complex sphingolipids with various 
structural and signaling functions within the cell (Spincemaille et al., 2014). 
Recent studies have suggested links between sphingolipids and the maintenance 
of mitochondrial function.  In C. elegans, mitochondrial defects are detected by a 
surveillance pathway, which induces the expression of drug-detoxification genes, such as 
cyp-14A3 (Menzel et al., 2007), and mitochondrial chaperone genes, such as hsp-6 
(Kimura et al., 2007).  One study demonstrated that inhibition of sphingolipid and 
ceramide synthesis, either genetically or pharmacologically, prevents nematodes from 
activating hsp-6 in response to mitochondrial stress by antimycin, but has no effect on 
activation of other stress-responsive genes when other organelles are stressed (Liu et al., 
2014).  Furthermore, they demonstrate that exogenous addition of C24-ceramide restores 
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the ability of the animals to induce hsp-6 in the presence of mitochondrial stress, but is 
not sufficient to induce hsp-6 absence of stress (Liu et al., 2014), suggesting that 
ceramide fulfills a role in the cell’s response to mitochondrial stress.  
In mammalian cells, various ceramide species have been shown to modulate 
mitochondrial function (Kogot-Levin and Saada, 2014).  Some ceramide species inhibit 
complexes of the electron transport chain, whereas other ceramide species demonstrate 
the opposite effect (Di Paola et al., 2000; Gudz et al., 1997).  Other experiments 
demonstrate that ceramides induce permeabilization of the outer mitochondrial 
membrane to initiate apoptosis (Colombini, 2010).  Another study suggests that the 
generation of C18-ceramide induces mitophagy, but that ceramides of different chain 
lengths do not (Sentelle et al., 2012).  It has also been shown that ceramides recruit 
mitochondrial fission machinery (Loson et al., 2013; Parra et al., 2008) and that 
inhibiting ceramide synthesis causes a reduction in fission machinery at mitochondria 
(Ciarlo et al., 2010).  Inhibiting sphingolipid synthesis with myriocin typically causes cell 
death; however, cells lacking mitochondrial DNA are resistant to myriocin-induced cell 
death (Kemmer et al. 2009).  Additionally, myriocin treatment in aged yeast was shown 
to upregulate many genes associated with mitochondrial function, autophagy, and stress 
response pathways, while simultaneously downregulating genes related to protein 
translation and lipid biosynthesis (Liu et al., 2013).   
Studies focused on the yeast inositol sphingolipid phospholipase C, Isc1, have 
provided several links between sphingolipids and mitochondrial function.  Under normal 
growth conditions, Isc1 is found in the endoplasmic reticulum (ER), but localizes to the 
mitochondria during post-diauxic growth (Vaena de Avalos et al., 2004; Vaena de Avalos 
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et al., 2005).  Isc1 is homologous to neutral sphingomyelinases in higher eukaryotes, 
some of which have been identified in mitochondrial membranes (Matmati and Hannun, 
2008; Yabu et al., 2009).  Isc1 hydrolyzes complex sphingolipids to produce ceramide.  
Mitochondria from isc1∆ cells grown to the post-diauxic phase have dramatically 
reduced levels of several ceramide species when compared to mitochondria from wild-
type (WT) cells (Barbosa et al., 2011; Kitagaki et al., 2007).  Several markers of 
mitochondrial dysfunction have been identified in isc1∆ cells, including increased 
mitochondrial fragmentation, abnormal mitochondrial morphology (Rego et al., 2012), 
and the inability to respire (Barbosa et al., 2012; Vaena de Avalos et al., 2005).  These 
data strongly suggest that elements of sphingolipid metabolism help modulate 
mitochondrial function. 
 
Sterols, sphingolipids, and Vms1 translocation 
Significant crosstalk takes place between sphingolipid and sterol metabolism.  In 
erg26∆ cells, reduced ergosterol methylation is accompanied by downregulation of 
ceramide biosynthesis and hydroxylation (Swain et al., 2002).  In mammalian cells, the 
inhibition of cholesterol biosynthesis with lovastatin causes a downregulation in ceramide 
production (Storey et al., 1998).  Furthermore, both cholesterol and ceramide 
biosynthesis are decreased with the loss of sterol regulation element-binding proteins 
(Veen and Lang, 2005).  Additional studies (Veen and Lang, 2005) have described 
genetic interactions between ELO3 and genes in the ergosterol biosynthetic pathway.  
Cells lacking Elo3 cannot synthesize long-chain fatty acids or sphingolipids, as long-
chain fatty acids are required for sphingolipid biosynthesis.  Deletion of ELO3 restores 
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viability to erg24∆ cells, but is synthetically lethal with the deletion of ERG6 (Eisenkolb 
et al., 2002), suggesting that certain sphingolipids have distinct relationships with specific 
sterols. 
 We have previously shown that Vms1 translocation is regulated through 
intramolecular interactions (Heo et al., 2013) and sterol oxidation.  A highly conserved 
domain, called the Mitochondrial Targeting Domain (Vms1MTD), is necessary and 
sufficient for mitochondrial targeting.  Under unstressed conditions, the Vms1MTD is 
autoinhibited through direct interactions with a Leucine Rich Sequence (Vms1LRS) and 
Vms1 localizes throughout the cytosol (Heo et al., 2013).  In response to certain stress 
conditions, the autoinhibitory interaction between the Vms1LRS and Vms1MTD is relieved, 
enabling Vms1 to bind mitochondria.  This stress-responsive mitochondrial translocation 
is likely facilitated by interactions between Vms1 and ergosterol peroxide (EP). 
There are multiple pieces of evidence indicating that lipid signaling is an 
important factor in regulating Vms1 translocation to mitochondria.  We have shown that 
Vms1 localization to mitochondria is dependent on the production of an oxidized sterol, 
EP (Figure 3.3).  Additionally, VMS1 and multiple genes encoding nonessential enzymes 
of the sphingolipid biosynthetic pathway (data not shown) have strong negative genetic 
interactions in Schizosaccaromyces pombe.  These observations, coupled with previously 
characterized roles for sphingolipids in modulating mitochondrial quality and function, 
and observed crosstalk between the sphingolipid and sterol biosynthetic pathways led us 





Sphingolipids synthesis and trafficking are necessary 
 for Vms1 localization and binding to mitochondria 
To determine if sphingolipids are necessary for constitutive and stress-responsive 
Vms1 localization to mitochondrial, we evaluated Vms1MTD and stress-responsive full-
length Vms1 localization to mitochondria in vehicle and myriocin-treated cells using 
fluorescent microscopy.  Myriocin inhibits serine-palmitoyl transferase (SPT), the 
enzyme that catalyzes the initial step in de novo sphingolipid biosynthesis.  We observed 
a substantial decrease in constitutive Vms1MTD and stress-responsive full-length Vms1 
localization to mitochondria in cells treated with myriocin (Figures 4.1A and 4.1B).  To 
determine if ceramides, a subset of sphingolipids, are necessary for Vms1 localization to 
a constitutive mitochondrial receptor, we depleted cells of ceramides by treatment with 
fumonisin B1, an inhibitor of ceramide synthase.  We observed a substantial decrease in 
constitutive Vms1MTD and stress-responsive full-length Vms1 localization to 
mitochondria in cells treated with fumonisin B1 (Figures 4.1A and 4.1B).   
Sphingolipids are not synthesized in mitochondrial membranes; rather, 
sphingolipids are imported into mitochondria from the ER (Tatsuta et al., 2014).  While 
the precise mechanism through which sphingolipids are imported to the mitochondria 
from the ER remains uncharacterized, it is likely that the ER-mitochondria encounter 
structure (ERMES) facilitates sphingolipid trafficking to mitochondria, similar to its 
function in trafficking phospholipids from the ER to mitochondria (Futerman, 2006).  To 
determine if impaired lipid trafficking from the ER to mitochondria affects Vms1 
localization to mitochondria, we evaluated Vms1MTD localization and stress-responsive 
78
full-length Vms1 localization to mitochondria in four different yeast strains, mmm1∆, 
mdm10∆, mdm12∆, and mdm34∆, each of which lacks a gene encoding a unique subunit 
of the ERMES complex.  Constitutive Vms1MTD and stress-responsive full-length Vms1 
localization to mitochondria were substantially reduced in each of these strains, whereas 
localization was only slightly affected in a cardiolipin synthesis mutant, crd1∆, 
suggesting that the reduction of Vms1 localization to mitochondria is not a general 
phenotype of all perturbations to mitochondrial lipid homeostasis (Figure 4.1A and 4.1B). 
We next sought to determine if the in vivo reduction of Vms1 localization to 
mitochondria was a direct result of altering sphingolipid levels in mitochondrial 
membranes.  To test this hypothesis, we purified recombinant Vms1 and isolated 
mitochondria from the same cells in which we observed a reduction in Vms1 localization 
by microscopy.  We evaluated Vms1 binding affinity to mitochondria by quantitating the 
amount of purified Vms1 that comigrated with mitochondria through a sucrose gradient 
upon ultracentrifugation.  We observed a similar reduction in Vms1 comigration with 
mitochondria that had been depleted of sphingolipids, either by preventing de novo 
synthesis of sphingolipids pharmacologically, or by preventing sphingolipid trafficking to 
mitochondria by genetically disrupting ERMES (Figure 4.2).  These in vivo and in vitro 
observations suggest that perturbations to sphingolipid synthesis and trafficking directly 
impede the ability of Vms1 to localize and bind to mitochondria. 
 
Sphingolipids contribute to in vitro Vms1 binding 
 At this point, we had observed that pharmacological inhibitions and genetic 
mutations that affect sphingolipid synthesis and trafficking also have an effect on Vms1 
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binding to mitochondria.  To determine if Vms1 binds sphingolipids in vitro, we isolated 
alkaline-resistant mitochondrial lipids from vehicle-treated and myriocin-treated cells.  
Myriocin inhibits de novo sphingolipid biosynthesis and treatment of total mitochondrial 
lipids with mild alkaline base hydrolyzes almost all phospholipids, leaving an alkaline-
resistant lipid sample that is enriched for sphingolipids and sterols (Guan et al., 2010).  
Because we isolated only the alkaline-resistant mitochondrial lipids, the major difference 
between the lipid isolates from vehicle and myriocin-treated cells should be the presence 
of sphingolipids in the vehicle-treated sample and the absence of sphingolipids in the 
myriocin-treated sample.  We created liposomes from these isolated lipids and assayed 
for Vms1 binding to sphingolipids in a liposome flotation assay.  We observed that the 
absence of sphingolipids from the liposome mixture caused a dramatic reduction in the 
ability of Vms1 to bind liposomes (Figure 4.3), suggesting that sphingolipids contribute 
to Vms1 binding to mitochondria. 
  
Vms1 can bind multiple glycosylated sphingolipids in vitro 
We wanted to identify which sphingolipid species Vms1 binds in vitro.  Initially, 
we took a simple biochemical approach and assayed for the ability of Vms1 to bind 
various commercially-available sphingolipid species that had been spotted on to 
nitrocellulose membranes.  We were surprised to observe that both yeast and human 
Vms1 bound specifically to sulfatide (Figure 4.4A and 4.4B).  Sulfatide is a sulfated 
galactosylceramide that does not exist in S. cerevisiae and is primarily found on the 
extracellular leaflet of the myelin plasma membrane of oligodendrocytes and Schwann 
cells (Xiao et al., 2013).  We postulated that Vms1 was not actually binding sulfatide, in 
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vivo, but that perhaps Vms1 binds a lipid with structures or moieties similar to those on 
sulfatide, specifically a charged group similar to a sulfate group and a hexose moiety 
similar to galactose.  This idea was further supported by the observation that Vms1 
moderately binds phosphatidylinositol phosphates, but only weakly binds 
phosphatidylinositol trisphosphate and bisphosphates (data not shown).   
In S. cerevisiae, there is a well-studied set of three complex ceramides containing 
a series of sugars and phosphate groups (Dickson and Lester, 1999).  These lipids were 
not available commercially and the procedures for isolating them were quite complex, so 
we were unable to directly test Vms1 binding to each.  Instead, we determined whether 
Vms1 localization to mitochondria was dependent on the presence of these complex 
ceramides by deleting the genes required for their synthesis.  We observed no change in 
the ability of Vms1 to localize to mitochondria in strains lacking these genes (data not 
shown), suggesting that these complex ceramides in S. cerevisiae are not required for 
Vms1 localization to mitochondria. 
While sulfatide has not been identified in yeast, its precursor, galactosylceramide, 
and the related species, glucosylceramide, have been identified in various yeast species 
(Saito et al., 2006; Wagner and Zofcsik, 1966).  We tested whether Vms1 could bind to 
liposomes containing either galactosylceramide or glucosylceramide.  While we never 
detected Vms1 binding to liposomes containing glucosylceramide, we did observe weak 
and inconsistent Vms1 binding to liposomes containing galactosylceramide (data not 
shown), suggesting galactosylceramide may play a modest role in binding Vms1.  From 
this inconsistent binding data, we hypothesized that galactosylceramide might be one of 
multiple species that contribute to Vms1 binding to mitochondria. 
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Vms1 localization to mitochondria strongly correlates  
with the levels of a glycosylated ergosterol,  
with one major outlier 
At this point, we transitioned from a directed approach to identify sphingolipid 
species that bind Vms1 in vitro to a comprehensive, unbiased approach to identify 
sphingolipids that are required for Vms1 localization to mitochondria in vivo.  We 
hypothesized that if we correlated the strength of in vivo Vms1MTD binding to 
mitochondria with the levels of various sphingolipid species across many genetic 
mutants, then the lipid species whose abundance correlated most strongly with Vms1MTD 
localization was likely a sphingolipid required for Vms1 localization to mitochondria.  
We obtained a large set of mutants, focusing on mutants that affect lipid synthesis, lipid 
trafficking, glycosyltransferase activity, and lipid modification (Table 4.1).  We used 
thin-layer chromatography (TLC) to separate lipid species and then quantitated the levels 
of various mitochondrial lipid species from each of these strains and from cells treated 
with myriocin (Table 4.2).  On a scale of 1-10, with 10 being complete Vms1MTD 
localization to mitochondria, we arbitrarily scored the strength of Vms1MTD localization to 
mitochondria in each of the strains from which we isolated lipids (Table 4.2).  We then 
created a scatterplot for each of the lipids we quantified, comparing the lipid abundance 
to the strength of Vms1MTD localization, where each dot represents a single mutant strain 
or pharmacological treatment.  Phosphatidylcholine and phosphatidylethanolamine levels 
remained constant across nearly all strains and conditions.  The levels of many other 
lipids also demonstrated no significant correlation with the strength of Vms1MTD 
localization.  A small number of lipid species, including α-hydroxy ceramide, showed 
82
moderate correlation, consistent with previous observations that sphingolipids are 
required for Vms1 localization to mitochondria.  Lastly, a single lipid species displayed 
very strong correlation between its abundance and Vms1MTD localization over all strains, 
except the atg26∆ strain (Figure 4.5). 
We utilized multiple analytical techniques to determine the molecular identity of 
this lipid species, anticipating that it would be a sphingolipid, possibly 
galactosylceramide, and that it would bind Vms1.  This lipid migrated on TLC with a 
similar retention factor to that of galactosylceramide.  When stained with orcinol, both 
our unknown species and galactosylceramide produced the same pink color, 
characteristic of a hexose-containing lipid (data not shown).  When we analyzed this 
unknown lipid band by mass spectrometry, we failed to identify any ions consistent with 
galactosylceramide.  Rather, the fragmentation pattern of this lipid species was consistent 
with ergosterol glucoside.  Interestingly, galactosylceramide and ergosterol glucoside 
have similar retention factors on TLC and when stained with orcinol, both produce a pink 
color (data not shown).  These data indicated that the sphingolipid we thought we were 
identifying was actually a glycosylated sterol.   
We introduced ergosterol glucoside into liposomes to determine if Vms1 was able 
to bind ergosterol glucoside in vitro.  Surprisingly, Vms1 displayed no affinity to 
ergosterol glucoside in liposome flotation assays, nor when spotted on nitrocellulose 
membranes, suggesting mitochondrial ergosterol glucoside does not bind Vms1 (data not 
shown).  Furthermore, ergosterol glucoside is produced when Atg26 catalyzes the 
glycosylation of ergosterol.  Vms1MTD localization to mitochondria is unimpaired by the 
deletion of ATG26 (Figure 4.5), indicating that ergosterol glucoside is not required for 
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Vms1 localization to mitochondria. 
 
Discussion 
 Herein we demonstrate that perturbing sphingolipid biosynthesis and trafficking 
to mitochondria reduces the ability of Vms1 to localize to mitochondria in vivo and bind 
membranes composed of mitochondrial lipids in vitro.  We were unable to identify 
unique lipid species that might act as endogenous receptors for Vms1 binding to 
mitochondria.  However, we did identify lipid species, such as sulfatide, capable of 
directly binding to Vms1 in vitro, but that are most likely not required for Vms1 
localization to mitochondria in vivo.  Perhaps there are unidentified structural 
homologues of these lipids that bind directly to Vms1 and contribute to Vms1 
recruitment to mitochondria. 
 Alternatively, sphingolipids may contribute to the formation of a type of lipid 
microdomain, which may be necessary for Vms1 to bind EP, a lipid we have previously 
shown to directly bind Vms1 in vitro and that is necessary for Vms1 localization to 
mitochondria.  The formation of lipid microdomains is thought to be a mechanism 
whereby cellular membranes are compartmentalized by the uneven distribution of 
specific lipids and proteins (Zheng et al., 2009).  Lipid rafts are a type of lipid 
microdomain enriched in sphingolipids and sterols.  It has been hypothesized that 
cholesterol is inserted between the rigid hydrophobic tails of sphingolipids and saturated 
phospholipids, creating a region of the membrane with unique biophysical properties 
(Zheng et al., 2009).  It is also supposed that certain proteins preferentially gather to these 
unique regions, which could enable hubs for cell signaling and trafficking (Brown and 
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Rose, 1992; Simons and Ikonen, 1997).  These theories remain controversial, including 
debate over the actual existence of lipid rafts in mitochondria (Bagnat et al., 2000; Zheng 
et al., 2009).  Nevertheless, we can envision a scenario in which sphingolipids contribute 
to the formation of lipid rafts containing EP.  These sphingolipids might be required to 
stabilize EP in the membrane or to present EP in a conformation recognizable to 
Vms1MTD.  Furthermore, the biophysical properties of these rafts could promote the 
recruitment of proteins destined for Vms1-dependent extraction and degradation by the 
proteasome.  In this scenario, sphingolipids would help create membrane regions in 
which the Vms1 receptor and substrates are spatially concentrated. 
 Several observations presented in this study are consistent with the hypothesis 
that sphingolipids stabilize sterols in mitochondrial membranes.  There are no studies 
describing a mechanism whereby myriocin would directly affect the synthesis of 
ergosterol or ergosterol derivatives.  Nevertheless, we observed that myriocin treatment 
causes a reduction in the levels of mitochondrial ergosterol glucoside.  Other 
perturbations to sphingolipid biosynthesis and trafficking to mitochondria also caused a 
reduction in the levels of mitochondrial ergosterol glucoside (Table 4.2).   
Interestingly, ergosterol glucoside and EP are both products of an ergosterol 
precursor.  Ergosterol is glycosylated by Atg26 to produce ergosterol glucoside 
(Warnecke et al., 1999), whereas ergosterol is nonenzymatically oxidized to generate EP 
(Böcking et al., 2000).  In our correlation analysis, we did not use enough mitochondria 
to be able to detect the very small amounts of EP.  Had we used larger amounts of 
material, we would have expected to see very strong correlation between EP levels and 
the strength of Vms1MTD localization.  Of all the genetic strains and pharmacological 
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treatments we used in our correlation analysis (Table 4.1), the only strain that directly 
affects a step unique to the biosynthesis of ergosterol glucoside is the atg26∆ strain, the 
only true outlier (Figure 4.5).  We could argue that all other strains have an indirect effect 
on general sterol biosynthesis and trafficking to mitochondria.  If this were true, then EP 
and ergosterol glucoside would produce nearly identical scatterplots comparing the 
strength Vms1MTD localization and lipid levels, with the exception of the atg26∆ strain.  
Since Vms1MTD localization to mitochondria is unimpaired by ATG26 deletion and EP 
synthesis should be unaffected by ATG26 deletion, the atg26∆ outlier observed in the 
ergosterol glucoside correlation plot would be absent in a correlation plot for EP.  This 
data would support the notion that EP is necessary for Vms1 localization to mitochondria. 
Similar to previous hypotheses (Zheng et al., 2009), sphingolipids may interact 
with sterols, such as EP, in mitochondrial membranes.  Interactions between 
sphingolipids and sterols may stabilize these sterols and help position these sterols in a 
specific conformation.  We hypothesize that in the absence of sphingolipids, EP becomes 
destabilized in the membrane or is unable to be positioned in a manner accessible to 
Vms1MTD, thereby disrupting Vms1 localization to mitochondria. 
 Data presented herein demonstrate that Vms1 localization to mitochondria 
depends on the production of ceramide, by ceramide synthase and Isc1 (Table 4.2).  
Previous studies have shown that Isc1 translocates to mitochondria during post-diauxic 
growth (Vaena de Avalos et al., 2004).  In some preliminary experiments, we observed 
Isc1 translocate to ERMES under CCCP and antimycin treatment, stress conditions that 
also promote Vms1 localization to mitochondria.  Isc1 translocation to ERMES in 
response to mitochondrial stress could promote an increase in mitochondrial ceramide 
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production.  This increase in ceramide levels, in response to mitochondrial stress, could 
contribute to the formation of additional mitochondrial lipid rafts capable of stabilizing 
increased levels of EP, consistent with observed increases in mitochondrial EP under 
stress conditions. 
 Sphingolipids, specifically ceramides, may fulfill additional roles in promoting 
mitochondrial protein degradation.  Several years ago, one study (Kitagaki et al., 2007) 
discovered a novel role for Isc1-dependent ceramide signaling.  They demonstrated that 
deletion of ISC1 results in dysregulation of genes involved in carbon metabolism, 
nutrient uptake, and amino acid metabolism.  Additional studies have described roles for 
sphingolipids in mediating responses to heat stress (Jenkins et al., 1997).  The activities 
of sphingolipid biosynthetic pathway enzymes are drastically altered in response to heat 
stress (Chen et al., 2013).  One study (Chung et al., 2000) showed that phytosphingosine 
activates ubiquitin-dependent proteolysis in response to heat stress.  Perhaps 
sphingolipids contribute both to proteasome activation and recruitment of Vms1 and 
other cellular machinery required to extract proteins destined for proteasomal 
degradation.  While a precise mechanism remains elusive, the data described herein 




Yeast strains, media, and growth conditions 
Saccharomyces cerevisiae strain JRY2509 (MATa his3 leu2 ura3 met15) was 
used as the WT strain.  Deletion mutant strains were taken from the Saccharomyces 
87
Genome Deletion Project (Giaever et al., 2002).  Complete strain information is given in 
Table 4.1.  Yeast were transformed by the lithium acetate method, and grown at 30°C in 
SD medium (0.67% yeast nitrogen base, 2% glucose) with amino acids unless otherwise 
indicated (Sherman, 1991).  To test the sphingolipid dependence of Vms1-mitochondria 
comigration, WT cells transformed with empty vector were grown to mid-log phase in 
SD-Ura medium and treated with equivalent volumes of vehicle (DMSO) or 1µg/mL 
myriocin (Sigma #M1177) for 2.5 hours before harvesting. 
 
Mitochondria purification 
Cells were exposed to the indicated conditions and harvested in mid-log phase.  
Mitochondria were then purified with ultracentrifugation of a sucrose gradient as 
previously described (Hao et al., 2009). 
 
Plasmids 
A plasmid (pJR132011A) expressing C-terminally GFP-tagged Vms1MTD was 
generated by PCR amplifying the VMS1 coding region from nucleotide 544 to 1251 and 
the VMS1 promoter from 335 nucleotides upstream to the VMS1 start codon from 
genomic DNA and ligating them in frame into a pRS416-based vector containing a GFP 
tag (pJR1415A).  A plasmid (pJR3462D) expressing C-terminally GFP-tagged Vms1 was 
generated as described (Heo et al. 2010). Mitochondria were identified with a plasmid 





The WT (JRY2509) or mutant strains were transformed with a plasmid expressing 
Vms1MTD -GFP under the native VMS1 promoter (pJR132011A) and a plasmid expressing 
mitochondrially-targeted RFP (pJR9509B).  The cells were grown to mid-log phase, 
treated with drug where indicated, and imaged using a Zeiss Axioplan 2 Imaging 
microscope (Carl Zeiss). 
 
Mitochondrial comigration assay 
100µg of purified mitochondria were incubated with 2.5µg of purified 10XHis-
Vms11-417-HA in 300µL of SEM buffer (250mM sucrose, 1mM EDTA, 10mM MOPS, 
pH 7.2) for 1 hour at 4˚C.  30µL was taken as an input control and the remaining mixture 
was loaded on a step-sucrose gradient (60%, 32%, 23%, 15% sucrose in a 1mM EDTA, 
10mM MOPS, pH 7.2 buffer).  Mitochondria-bound Vms1 was separated from unbound 
Vms1 by high speed ultracentrifugation as described (Meisinger et al., 2000).  After 
centrifugation, fractions were collected and analyzed by SDS-PAGE and Western blot 
with α-His6 (Clontech #631212) and α-Por1 (Abcam #110326) antibodies. 
 
Lipid isolation and alkaline hydrolysis 
Lipids were isolated from mitochondria using a modified Folch extraction.  
Pelleted mitochondria (1-5mg as measured by protein concentration) were resuspended in 
500µL of PBS (Gibco), 500µL of methanol (Sigma), and 1mL of chloroform (Fischer 
Scientific) and vortexed at high speed for 10 minutes.  The resulting mixture was then 
centrifuged for 2 minutes at 1000xg.  The lower organic phase was transferred to a new 
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tube and the remaining aqueous phase was extracted with chloroform two additional 
times.  The pooled organic extracts were then washed twice with water.  The washed 
organic extract was then evaporated by SpeedVac (Savant) to yield a lipid film.  This 
lipid film was then analyzed as a total lipid fraction or subjected to NaOH hydrolysis as 
previously described (Guan et al., 2010) to create an alkaline-resistant lipid fraction 
enriched for sterols, sphingolipids, and isoprenoids. 
 
Liposome preparation 
A lipid solution was prepared by mixing 793µg of DOPC (Avanti #850375P), 
98µg of cholesterol (Avanti #700000P), and alkaline-resistant lipids from ~1mg of 
mitochondria isolated from untreated or myriocin cells.  Solvent was evaporated by 
gentle vortexing under a steady stream of argon gas to make a lipid film around the walls 
of the vial. These films were dried under vacuum for 1 hour at -52˚C.  The lipid film was 
then solubilized in hexane (Sigma) and subsequently evaporated under a gentle stream of 
argon while vortexing, followed by a subsequent round of drying under vacuum for 3 to 4 
hours at -52˚C.  Lipid films were then hydrated with TBS (25mM Tris, 150mM NaCl, pH 
7.5) to produce a 1mg lipid/mL buffer mixture.  This mixture was rotated overnight at 
4˚C and then extruded through 1.0µM membranes (Fischer Scientific #05-71-5120) to 
produce a semi-homogenous liposome population.  Aliquots were stored at -80˚C. 
 
Liposome flotation assay 
100µL of liposomes were incubated with 2.5µg of purified 10XHis-Vms11-417-HA 
at 4˚C for 1 hour.  10µL of the mixture was taken as an input control.  300µL of 2M 
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sucrose in TBS was added to the liposome-protein mixture and mixed well.  A step-
sucrose gradient was then created by gently loading 300µL of 1M sucrose in TBS on top 
of the liposome mixture, followed by 300µL of 0.5M sucrose in TBS, and finally 75µL of 
TBS.  This gradient was then spun for 30 minutes in a Beckman Optima-Max table-top 
ultracentrifuge at 55,000rpm allowing the liposomes to float to the top of the gradient, 
separating liposome-bound protein from unbound protein (Koirala et al., 2013).  150µL 
was taken from the top (bound Vms1) and bottom (unbound Vms1) of the sucrose 
gradient and analyzed by SDS-PAGE and Western blot with α-His6 antibody (Clontech 
#631212). 
 
Thin-layer chromatography (TLC) and orcinol stain 
Lipids were dissolved in 1:1 chloroform:methanol and spotted on to TLC plates 
(EMD Millipore #1.05554.0001).  To resolve sterols and sphingolipids, the TLC was 
resolved in a 10:1 chloroform:methanol solvent system.  To resolve phospholipids, the 
TLC was resolved as described (Medh and Weigel, 1989).  TLC plates were stained with 
an orcinol solution.  200mg of orcinol (Sigma) were dissolved in 11.4mL of H2SO4 and 
brought up to 100mL with water.  Resolved TLC plates were submerged briefly in the 
orcinol solution, left to air dry for 5 minutes, and then heated on a hot plate at ~95˚C until 
bands appeared.  Lipid bands were quantified using ImageJ software. 
 
Lipid blot 
Nitrocellulose membranes spotted with various sphingolipids (Echelon 
Biosciences #S-6000) were blocked with 3% fatty-acid free BSA (Sigma #A6003) in 
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TBS for 1 hour at room temperature.  The blocking solution was then replaced with a 
1µg/mL solution of 10XHis-Vms11-417-HA or 10XHis-hVMS1 in TBS with 3% fatty-acid 
free BSA and incubated overnight at 4˚C.  The membrane was then subjected to standard 
Western blot techniques with 1˚ and 2˚ antibody incubation in TBS with 3% fatty-acid 
free BSA to visualize protein-lipid binding. 
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Figure 4.1.  Perturbing sphingolipid synthesis or trafficking reduces Vms1 
localization to mitochondria. 
A. WT cells were transformed with a plasmid expressing Vms1MTD-GFP under the native 
VMS1 promoter and a plasmid expressing mitochondrially-targeted RFP, grown to mid-
log phase, and subjected to varying treatments (1µg/mL myriocin for 2.5 hours or 100µM 
fumonisin B1 in 0.5% NP40 for 90 minutes).  The indicated genetic mutants were also 
transformed with the same plasmids and grown to mid-log phase.  Cells from each 
condition or background were subjected to fluorescence microscopy.  B. The same strains 
described in A were transformed with a plasmid expressing Vms1-GFP under the native 
VMS1 promoter and a plasmid expressing mitochondrially-targeted RFP.  These cells 
were exposed to the same treatments described in A, with the addition of a 3mM H2O2 
treatment 75 minutes prior to fluorescent microscopy. 
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Figure 4.2.  Perturbing sphingolipid synthesis or trafficking reduces Vms1 binding 
to mitochondria. 
Purified 10XHis-Vms11-417-HA was mixed with mitochondria isolated from untreated WT, 
myriocin-treated WT, untreated ∆mdm12, or untreated ∆crd1 cells, and subjected to the 
sucrose gradient centrifugation as described. 			
		
Figure 4.3.  Sphingolipids are required for efficient binding to liposomes. 
Mitochondrial alkaline-resistant lipids from untreated or myriocin-treated cells were used 
to make liposomes as described. These liposomes were then subjected to the flotation 


























Figure 4.4.  Vms1 binds specifically to sulfatide in vitro, a sulfated glycoceramide. 
A. Purified 10XHis-Vms11-417-HA was incubated with nitrocellulose membranes spotted 
with 100pmols of various sphingolipids and visualized as described.  B. Purified 10XHis-
hVMS1 was incubated with nitrocellulose membranes spotted with 100pmols of various 








































Figure 4.5.  Vms1MTD localization and levels of ergosterol glucoside strongly 
correlate, with the exception of a single outlier. 
Vms1MTD localization to mitochondria in various strains, as monitored by fluorescence 
microscopy, was scored on a scale of 1-10 and correlated with the abundance of 
ergosterol glucoside which was normalized to mitochondrial phosphatidylethanolmine. 	
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Table 4.1.  Strains used to correlate Vms1MTD localization and lipid levels. 
Strain Genotype Source 
WT (JRY2509) MATa his3 leu2 ura3 met15 This study 
atg26∆ MATa his3 leu2 ura3 met15 atg26::kanMX (Giaever et al., 2002) 
crd1∆ MATa his3 leu2 ura3 met15 crd1::kanMX (Giaever et al., 2002) 
csg2∆ MATa his3 leu2 ura3 met15 csg2::kanMX (Giaever et al., 2002) 
dpl1∆ MATa his3 leu2 ura3 met15 dpl1::kanMX (Giaever et al., 2002) 
erg2∆ MATa his3 leu2 ura3 met15 erg2::kanMX (Giaever et al., 2002) 
erg24∆ MATa his3 leu2 ura3 met15 erg24::kanMX (Giaever et al., 2002) 
erg3∆ MATa his3 leu2 ura3 met15 erg3::kanMX (Giaever et al., 2002) 
erg4∆ MATa his3 leu2 ura3 met15 erg4::kanMX (Giaever et al., 2002) 
erg5∆ MATa his3 leu2 ura3 met15 erg5::kanMX (Giaever et al., 2002) 
erg6∆ MATa his3 leu2 ura3 met15 erg6::kanMX (Giaever et al., 2002) 
fks3∆ MATa his3 leu2 ura3 met15 fks3::kanMX (Giaever et al., 2002) 
gph1∆ MATa his3 leu2 ura3 met15 gph1::kanMX (Giaever et al., 2002) 
gsy1∆ MATa his3 leu2 ura3 met15 gsy1::kanMX (Giaever et al., 2002) 
gsy2∆ MATa his3 leu2 ura3 met15 gsy2::kanMX (Giaever et al., 2002) 
isc1∆ MATa his3 leu2 ura3 met15 isc1::kanMX (Giaever et al., 2002) 
ktr3∆ MATa his3 leu2 ura3 met15 ktr3::kanMX (Giaever et al., 2002) 
ltc1∆ MATa his3 leu2 ura3 met15 ltc1::kanMX (Giaever et al., 2002) 
mdm10∆ MATa his3 leu2 ura3 met15 mdm10::kanMX (Giaever et al., 2002) 
mdm12∆ MATa his3 leu2 ura3 met15 mdm12::kanMX (Giaever et al., 2002) 
mdm34∆ MATa his3 leu2 ura3 met15 mdm34::kanMX (Giaever et al., 2002) 
mmm1∆ MATa his3 leu2 ura3 met15 mmm1::kanMX (Giaever et al., 2002) 
mnt4∆ MATa his3 leu2 ura3 met15 mnt4::kanMX (Giaever et al., 2002) 
pmt1∆ MATa his3 leu2 ura3 met15 pmt1::kanMX (Giaever et al., 2002) 
pmt2∆ MATa his3 leu2 ura3 met15 pmt2::kanMX (Giaever et al., 2002) 
pmt7∆ MATa his3 leu2 ura3 met15 pmt7::kanMX (Giaever et al., 2002) 
sac1∆ MATa his3 leu2 ura3 met15 sac1::kanMX (Giaever et al., 2002) 
scs7∆ MATa his3 leu2 ura3 met15 scs7::kanMX (Giaever et al., 2002) 
sur1∆ MATa his3 leu2 ura3 met15 sur1::kanMX (Giaever et al., 2002) 
ups1∆ MATa his3 leu2 ura3 met15 ups1::kanMX (Giaever et al., 2002) 





Table 4.2.  Mitochondrial Vms1MTD localization and ergosterol glucoside levels. 
Strain Vms1MTD localization score Ergosterol glucoside levels 
WT (JRY 2509) 9.0 1.00 
myriocin 1.0 0.07 
atg26∆ 9.0 0.06 
crd1∆ 6.0 0.86 
csg2∆ 6.5 0.66 
dpl1∆ 7.0 0.45 
erg2∆ 2.0 0.59 
erg24∆ 5.5 0.58 
erg3∆ 2.0 0.16 
erg4∆ 4.5 0.76 
erg5∆ 5.0 1.00 
erg6∆ 4.5 0.59 
fks3∆ 5.0 0.56 
gph1∆ 2.0 0.12 
gsy1∆ 8.5 1.00 
gsy2∆ 1.5 0.16 
isc1∆ 5.5 0.62 
ktr3∆ 6.5 0.73 
ltc1∆ 8.0 1.04 
mdm10∆ 1.5 0.02 
mdm12∆ 5.0 0.42 
mdm34∆ 4.5 0.33 
mmm1∆ 5.0 0.67 
mnt4∆ 7.0 0.73 
pmt1∆ 3.0 0.42 
pmt2∆ 4.0 0.67 
pmt7∆ 3.5 0.44 
sac1∆ 7.0 0.56 
scs7∆ 4.5 0.61 
sur1∆ 4.5 0.27 
ups1∆ 2.0 0.02 









Accumulation of damaged proteins in mitochondria disrupts normal mitochondria 
function and leads to their dysfunction.  As mentioned previously, dysfunctional 
mitochondria contribute to an array of diseases and disorders.  To prevent the 
accumulation of dysfunctional mitochondria, cells have developed pathways that 
eliminate damaged mitochondrial proteins or that are capable of eliminating entire 
organelles that have become damaged or dysfunctional. 
One can imagine how the removal and degradation of entire mitochondria 
organelles would be very costly to the cell, compared with the removal of just the 
damaged proteins (Shirihai et al., 2015).  Synthesizing, modifying, and organizing the 
individual molecules necessary to create a new organelle would require significant time 
and energy.  Therefore, it is important for cells to have a mechanism whereby they can 
identify and provide assistance to stressed organelles, before the organelles become 
“damaged beyond repair.” 
Over the last several years, we have characterized such a pathway.  We have 
identified a protein, Vms1, which constitutively binds to Cdc48.  Through a conserved 
Vms1MTD domain, this Vms1-Cdc48 complex is recruited to damaged mitochondria in 
response to stress, where Cdc48 is thought to remove damaged proteins from the outer 
mitochondrial membrane (OMM).  This Vms1-Cdc48 complex makes up part of a 
mechanism that identifies and assists stressed mitochondria organelles, before they 
become too damaged and have to be degraded entirely (Heo et al., 2010).  Furthermore, 
we have identified a potential mechanism whereby Vms1 distinguishes between 
unstressed and stressed organelles, enabling the Vms1-Cdc48 complex to preferentially 
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localize to stressed organelles (Heo et al., 2013).   
The mechanism through which Vms1 can identify damaged organelles centers 
around sterol oxidation.  The oxidation of ergosterol by reactive oxygen species (ROS) 
produces ergosterol peroxide (EP) (Bocking et al., 2000), a lipid that is required for 
Vms1 localization to mitochondria.  Stress conditions lead to elevated levels of 
mitochondrial EP.  These same stress conditions cause intact mitochondria and liposomes 
prepared from mitochondrial lipids, both of which have increased levels of EP, to exhibit 
enhanced affinity towards Vms1.  Furthermore, Vms1 binding to liposomes containing 
mitochondrial lipids is enhanced by the addition of exogenous EP.  This evidence 
supports a model in which the conversion of ergosterol to EP by reactive oxygen recruits 
Vms1 to damaged mitochondria.   
Mitochondria are constantly producing some level of ROS.  When there are 
sufficient ROS to damage mitochondria, these damaged organelles produce more ROS, 
leading to more damage and more ROS, in a vicious cycle (Kurihara et al., 2012).  We 
hypothesize that EP acts as a biological rheostat, manifesting the local levels of oxidative 
stress, and promoting Vms1 localization to mitochondria as needed, similar to the graded 
signaling of MAP kinase during yeast mating (Bardwell, 2008).  Because EP is non-
enzymatically produced by ergosterol oxidation, EP serves as a readout of the ROS levels 
within the organelle, allowing Vms1 to monitor and provide assistance at a level 
commensurate with the levels of oxidative stress in a specific organelle.   
The notion that ROS contribute to cell signaling pathways is not a new idea.  One 
of the best-understood examples in which ROS regulate cell signaling is in the cells 
response to hypoxia.  Under hypoxic conditions, mitochondria release H2O2 in order to 
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activate the transcription factor hypoxia inducible factor 1 (HIF-1).  HIF-1 then induces 
the expression of erythropoietin to increase production of red blood cells, vascular 
endothelial growth factor (VEGF) to promote blood vessel biogenesis, and glycolytic 
enzymes to maintain ATP levels (Chandel et al., 1998).  Mitochondrial ROS also help to 
regulate autophagy, immunity, differentiation, aging, and other adaptations to stress 
(Sena and Chandel, 2012).  From the many studies on the mechanisms through which 
ROS participate in cell signaling, it is apparent that low levels of ROS are required for 
normal cell homeostasis.  Mitochondrial ROS are usually induced by various stressors, 
including hypoxia, starvation, and infection.  In this manner, the levels of mitochondrial 
ROS act as an alarm for the cell, with the ROS levels correlating with the severity of the 
stress with which the cell is confronted.  Extreme stress will induce the production of 
high levels of mitochondrial ROS, leading to excessive oxidative damage to proteins, 
lipids, and nucleic acids, and subsequent cell death.  Moreover, a moderate stressor will 
induce smaller quantities of ROS and oxidative damage, enabling the cell to adapt to the 
stress (Sena and Chandel, 2012).   
The studies surrounding Vms1 presented in this dissertation further demonstrate 
how cells use variable levels of mitochondrial ROS as signals.  Vms1 does not recruit 
Cdc48 to mitochondria under unstressed conditions, despite the presence of low levels of 
EP on mitochondria.  However, we see that Vms1 localization to mitochondria increases 
as the oxidative stress to which mitochondria are exposed increases (Figure 2.6A).  We 
propose that a certain threshold of oxidative stress, and subsequent EP abundance, is 
required to initiate Vms1 localization.  Upon reaching that threshold, we suggest that the 
increase in Vms1 localization would correlate with the increasing levels of oxidative 
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stress and EP. 
The integration of ROS, sterol signaling, and mitochondrial quality control 
through the Ubiquitin-Proteasome System (UPS) is quite novel.  Lipid signaling 
pathways, mostly dependent on ceramide, are well-known contributors to mitophagy 
(Sentelle et al., 2012).  However, lipid signaling to eliminate just the damaged proteins 
and preserve the organelle has not been previously described.  Singlet oxygen has been 
previously implicated as a marker for chloroplast stress, but neither the ligand with which 
singlet oxygen reacts to propagate the stress signal in plants, nor the mechanism whereby 
assistance is provided to the stressed chloroplasts, have been identified (Woodson, 2016).  
The studies described in this dissertation provide a novel and unique perspective on the 
cooperation and integration of multiple pathways within the cell. 
While we were able to increase our understanding of lipid signaling and stress-
responsive mitochondrial quality control, many questions remain or can now be asked.  
We have an increased understanding of how Vms1 is recruited to mitochondria, but why 
Vms1 is recruited to mitochondria is largely a mystery.  The tools we have used to 
promote Vms1 localization, such as rapamycin and H2O2 treatment, are quite blunt and do 
not target one specific pathway.  What is the actual biological event that induces ROS 
oxidation of ergosterol to produce EP and promote Vms1 localization? 
We have made major strides in understanding the mechanism of how Vms1 
localizes to mitochondria, but there is much we still need to understand.  It seems 
unlikely that EP is the sole species responsible for stress-responsive Vms1 localization to 
mitochondria.  What additional molecules, lipid or otherwise, contribute to the stress-
responsive localization of Vms1?  Specifically, how do sphingolipids contribute to this 
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process?  How does the Vms1LRS inhibit the Vms1MTD from binding the low levels of EP 
in unstressed conditions?  If the Vms1LRS and EP directly compete with each other for 
binding to a single surface on the Vms1MTD, for which we do have some evidence, then 
what does the Vms1LRS do when the Vms1MTD binds EP?  Might the Vms1LRS intercalate 
with the lipid bilayer and provide additional binding energy to stabilize the interaction 
between Vms1 and the OMM?  Consistent with this line of thinking, is Vms1 binding to 
EP like a canonical receptor, or does EP “unlock” Vms1, enabling the Vms1MTD or 
Vms1LRS to bind additional ligands that stabilize Vms1 binding to the membrane?  
Ergosterol is not produced in mammalian cells; rather, cholesterol is the major sterol.  
How conserved is this integrated pathway in higher eukaryotes?   
The last several years have expanded our understanding of how mitochondrial 
ROS can affect mechanisms of mitochondrial quality control.  Cells have evolved in such 
a way that they can use the same ROS that damages macromolecules to create the 
receptor to which the machinery required to repair this damage localizes.  While we were 
able to provide answers to several questions regarding the mechanism whereby Vms1 
localizes to mitochondria in response to stress, the true value of these studies is not 
measured solely by the questions we answered, but by the new questions we can now ask. 
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